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Compliance Adherence to a recommended treatment course 
Effectiveness The extent to which something is successful in producing 
the desired result 
 
Screening A method used to identify the presence of conditions 
among individuals with no signs or symptoms 
Spectacles  Optical devices used in ophthalmology to correct certain 
eye defects 
List of abbreviations 
 
LMIC Low and middle-income countries 
 
RCTs Randomized control trials 
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PROSPERO Prospective register of systematic reviews protocols 
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Development and Evaluation 
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SYNOPSIS 
 
This Master of Public Health (MPH) mini-dissertation undertakes a systematic 
review to assess the effectiveness of school vision screening programs in reducing 
children with uncorrected refractive error in low and middle-income countries 
(LMIC) 
 
 
This dissertation is in three parts; 
 
 
Part A is a research protocol which highlights the processes guiding the conduct of 
this systematic review and provide background information on both the condition 
(refractive error) and health intervention (school vision screening program) being 
investigated. 
 
 
Part B is a review of current literature on refractive error and school vision screening 
programs and highlights why the need on assessing the effectiveness of school 
screening programs in reducing children with uncorrected refractive error in LMIC 
is deemed necessary. 
 
 
Part C presents the entire research in a format that is suitable for publication in 
the PLOS ONE journal. 
9 | P a g e  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PART A: PROTOCOL 
10 | P a g e  
Part A: protocol 
1.0 Background ....................................................................................................... 11 
2.0 Objective .......................................................................................................... 12 
3.0 Methods……………………………………………………………………….12 
3.1 Criteria for considering studies for this systematic review ........................... 13 
3.1.1 Types of Studies .................................................................................... 13 
3.1.2 Type of Participants ............................................................................... 13 
3.1.3 Types of outcome measures ...................................................................13 
3.2 Search methods............................................................................................. 14 
3.2.1 Identification of studies ......................................................................... 15 
3.3 Data collection and analysis ......................................................................... 15 
3.3.1 Selection of Studies ............................................................................... 16 
3.3.2 Data extraction and management ........................................................... 16 
3.3.3 Assessment of risk of bias in included studies ...................................... 16 
3.3.4 Subgroup analysis .................................................................................. 17 
3.3.5 Dealing with missing data ..................................................................... 17 
3.3.6 Heterogeneity assessment ...................................................................... 17 
3.3.7 Data synthesis and analysis ................................................................... 16 
3.3.9 Grading the quality of evidence ............................................................. 18 
3.3.9 Reporting ............................................................................................... 18 
               3.4 Ethics..............................................................................................……….19 
3.4 Conflict of Interest & funding source ............................................................ 19 
11 | P a g e  
1.0 Background 
 
Population-based studies from different countries across the world have shown 
refractive error to be a major cause of visual impairment especially among children 
of school-going age (1-4). An increase in the number of children living with the 
condition in recent times has also been reported in a number of studies conducted 
among school children in Asia and other LMIC (4-7). Uncorrected refractive error 
has therefore been declared an issue of public health concern by the WHO (8). In 
eyes with uncorrected refractive error, parallel rays of light from a distant object are 
focussed either in front or behind the retina with accommodation fully relaxed (9). 
This leads to blurry visions in those affected. 
 
Due to the negative impact of uncorrected refractive error on the academic 
performance and overall quality of life of children affected, early detection and 
correction of the condition have been given top priority under the World Health 
Organization’s (WHO) vision 2020 initiative. Central to the various intervention 
programs suggested by the WHO to help deal with the condition is school vision 
screening. This involves the use of a simple visual acuity test to identify school 
children suffering from the condition and providing them with appropriate 
spectacle or contact lens correction (10). 
 
 
School vision screening programmes are relatively common in high income 
countries in Europe and America compared to Low and Middle-income 
countries in Africa and Asia (11). Few countries in LMIC settings have 
introduced school vision screening programs into their health care delivery 
system. Various factors have been cited for the lack of stakeholder’s 
commitment towards the introduction of the 
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program in LMIC. These include inadequate infrastructure, lack of funding, a 
limited number of eye care professionals and lack of evidence to show whether 
the program is effective in reducing the number of children with uncorrected 
refractive error in the long term (12, 13). 
 
 
Considering the fact that the prevalence of uncorrected refractive error among 
school children in LMIC is on the rise and school vision screening programs 
are currently being advocated for to help deal with the situation, a systematic 
review that examines all available studies assessing the effectiveness of the 
program with the aim of appropriately informing the introduction of future 
programs is deemed necessary and is the is focus of this thesis. 
 
 
2.0 Objective 
 
1. Evaluate the effectiveness of school vision screening programs in LMIC to 
reduce the proportion of children with uncorrected refractive error. 
 
 
3.0 Methods 
 
This protocol has been registered with the International prospective register of 
systematic reviews (PROSPERO) with registration number CRD42018089631. The 
protocol also follows the preferred reporting item for systematic review and meta-
analysis (PRISMA) guidelines (14) as shown in appendix 5.4 
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3.1 Criteria for considering studies for this systematic review 
 
3.1.1 Types of Studies 
 
 RCTs, cross-sectional studies, case-control studies, and cohort studies 
 
 
 
3.1.2 Type of Participants 
 
Children who have undergone vision screening as part of school vision screening 
programs in the LMIC setting and found to have a refractive error. Participants with 
other ocular pathologies accounting for poor vision will be excluded from this 
systematic review. 
 
 
3.1.3 Types of outcome measure 
Primary Outcome 
The proportion of children with uncorrected or sub-optimally corrected refractive error. 
 
 
 
Secondary outcomes 
 
 Long term effect of school screening programs on the academic 
performance of participants 
 The adverse effect of school vision screening programs (i.e. anxiety 
from interviews, misdiagnosis, symptoms associated with the use of 
prescribed spectacles, etc.) 
 Cost-effectiveness of school vision screening programs. 
 
 Influence of school vision screening programs on compliance with 
spectacle wearing. 
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3.2 Search methods 
 
3.2.1 Identification of studies 
 
To identify studies suitable for this systematic review, a comprehensive and 
systematic search strategy will be employed. A search of eligible articles will be 
performed using keywords, truncated terms, the Boolean operator and Medical 
Subject Heading (MESH) terms. Search will be restricted to articles published 
between 1980 and 2018 and search for articles will be done from January to June 
August 2018. The following electronic database will be searched PubMed, Cochrane 
Central Register of controlled trials (CENTRAL) which contains the Cochrane Eyes 
and vision Trial Register, the Cochrane Library, Medline (1980- 2018), CINAHL, 
Academic Search Premier, Web of Science, the WHO’s Library Information System, 
Africa-Wide and Scopus. Combined search of MESH terms, titles and abstract will 
be used for each step of the search. Search will be restricted only to articles written 
in English. Since this systematic review seeks to summarize evidence on the 
effectiveness of school vision screening programs to reduce the proportion of 
children with uncorrected refractive error, studies involving vision screening 
programs that targeted subgroup population such as children with specific ocular 
pathologies other than a refractive error (e.g. congenital glaucoma, congenital 
cataract, etc.) will be excluded. 
Filters will also be used during the search for articles to ensure that only studies in 
LMIC are included in this systematic review. Countries names and regional names 
will be used in the electronic search. This is to ensure that both country-specific 
records and records indexed by a regional term such as ‘West Africa’ are included in 
this systematic review. In instances where a country has English and local name, 
both names will be used to increase the sensitivity of the electronic search in 
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identifying all the relevant articles for the review. Efforts will be made to identify 
unpublished studies, government reports, theses, dissertation and conference papers 
by searching google (including google scholar) and WorldCat. Additionally, the 
reference list of all the included studies will also be searched for any articles that 
may have been missed during the initial search. A detailed description of the search 
strategies used is included in appendix 5.1 
 
3.3 Data collection and analysis 
 
3.3.1 Selection of Studies 
 
Selection of studies to be included in this systematic review will go through three 
phases involving two independent reviewers. In the first phase, two reviewers will 
check the electronic search result and select all studies that made reference to 
refractive error, myopia, hyperopia, astigmatism, and vision screening. Any 
identified article that is found to be clearly irrelevant at first glance will be excluded. 
In the second phase of the selection process, two independent reviewers will screen 
the titles and abstracts of studies identified to be relevant in the first phase to 
determine their eligibility for inclusion in this systematic review. The full text will be 
obtained for studies that have no abstract. In the third and final phase of the selection 
process, the two independent reviewers will perform a full-text review of all articles 
whose abstracts were found to be relevant in the second phase. A full-text review 
will also be done for articles whose abstract failed to provide a clear description of 
the study. 
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Using the study’s inclusion and exclusion criteria, the two reviewers will finally 
select the studies to be included in the systematic review. In instances where the two 
reviewers are unable to determine whether a study is eligible for inclusion, an 
arbitrator who is an expert in the field will be consulted. 
3.3.2 Data extraction and management 
 
Data from the selected studies will be extracted using a standardized Cochrane 
collaboration data extraction form that will be modified to suit this systematic 
review. (Attached as Appendix 5.2). Initial piloting of the data extraction form will 
be done to ensure uniformity among the two independent reviewers. Wherever 
possible, reviewers will extract information on study participants including their age, 
sex, school grade and the number of participants. An epidemiologic measure of the 
frequency and/or indicators of the severity of refractive error will also be extracted. 
Additionally, any data deemed to be an appropriate indicator of the effectiveness of 
school vision screening program such as the number of people who have benefited 
from spectacle correction of their refractive error, etc. will also be extracted. 
 
 
3.3.3 Assessment of risk of bias in included studies 
 
Assessment of risk of bias for cross-section and prevalence studies will be done 
using the Hoy criteria tool (attached as appendix 5.3a). For RCTs investigating the 
effectiveness of school vision screening programs in reducing the proportion of 
school children with uncorrected refractive error, risk of bias will be assessed using 
the Cochrane Effective Practice and Organization of Care (EPOC) tool (Attached as 
appendix 5.3b). Risk of bias for cohort studies will be assessed using the Cochrane 
risk of bias tool for cohort studies. Where and when deemed necessary, the funnel 
plot will be used to check for publication bias across the studies included in this 
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review. 
3.3.4 Subgroup analysis 
 
When and where appropriate, subgroup analysis will be done to determine the effect 
of the definition used as an indication of spectacle compliance on the pooled 
spectacle compliance. 
 
 
3.3.5 Dealing with missing data 
 
In instances where data is found to be missing in the studies included in this systematic 
review, efforts will be made to retrieve them by contacting the corresponding authors 
either through emails or contact details provided at the time of publication. In cases 
where missing data of studies cannot be retrieved because authors no longer have 
access to them or authors could not be contacted, such studies will be excluded from 
this systematic review and their impact on the review will be appropriately reported. 
 
 
3.3.6 Heterogeneity assessment 
 
Studies included in this systematic review will be check for heterogeneity by 
examining their characteristics (study design, population, setting, etc.). The 
Cochran’s Q-test and the Higgins Chi-square test for heterogeneity will be used to 
statistically explore any heterogeneity among the included studies. In addition, the 
confidence interval of the various studies will also be examined for any overlap using 
the forest plot where necessary. 
 
 
 
3.3.7 Data synthesis and analysis 
Analysis of quantitative data will be done using RevMan 5.3 software. In instances 
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where data from included studies are dichotomous, risk difference and proportion 
will be used as the measure of effect and in all instances, the 95% confidence interval 
will be presented. For studies with continuous data, the weighted mean with their 
corresponding 95% confidence interval will be used as the measure of effect. 
Additionally, the STATA 14 statistical package will be used to obtain estimates of 
the proportion of children with an uncorrected refractive error where necessary. In 
cases where statistical analysis of data is not possible, a narrative technique will be 
employed in presenting the result. A subgroup analysis will be done where deemed 
necessary to examine the impact of the definition used as an indication of spectacle 
compliance on the overall estimate of spectacle compliance. Cluster RCTs will be 
analyzed according to the guidelines in Chapter 16 of the Cochrane Handbook for 
Systematic Reviews of Interventions. 
 
 
3.3.8 Grading the quality of evidence 
 
The quality of the evidence presented in this systematic review will be assessed using 
the Grading of Recommendations Assessment, Development and Evaluation 
(GRADE) approach. Based on the level of confidence we have in the outcome, we 
will consider the methodological quality of included studies and strength of evidence 
and adapt the basic principles of the GRADE approach (15). 
 
 
3.3.9 Reporting 
 
The findings of this systematic review will be published is a recognizable peer- 
review journal 
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3.4 Ethics 
 
Since this review will make use of secondary data which will be extracted from 
published studies, there will be no need to obtain ethical approval. A waiver for ethical 
clearance will, however, be sought from the Health Science Research Committee at 
the University of Cape Town in South Africa. 
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1.0 Refractive Error 
 
Refractive error is a relatively common defect of the eye in which rays of light from 
a distant object are focused either in front or behind the retina of the eye with 
accommodation fully relaxed (16, 17). There are three main types of refractive error 
which affect people of all ages, sex, and race. These include myopia, hyperopia, and 
astigmatism. 
 
1.1 Myopia 
 
Myopia is a type of refractive error in which rays of light from a distant object are 
focused in front of the retina of the eye with accommodation fully relaxed. 
 
 
Figure 1: Focus of image in front of the retina in myopia (source: National Eye 
Institute) 
Several risk factors predispose a person to the development of myopia. This 
includes heredity, education and near work (18-20). Among these, 
environmental factors have been shown in a number of studies to be a 
predominant determinant of the current pattern of the condition (20-22). Myopia 
is a common cause of vision loss, with its progression being a major risk factor 
for sight-threatening eye conditions like retinal detachment (23).
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Myopia development has also been associated with certain environmental and  
school related factors such as reading, writing, and visual work when using  
a computer (20-22). Encouraging Outdoor activities that require less  
close work is currently believed by many researches to be effective in reducing  
the prevalence of myopia and it progression 
 
1.2 Hyperopia 
 
In hyperopia, parallel rays of light from optical infinity are refracted to a focus 
behind the retina. 
 
 
Figure 2: Focus of image behind the retina in hyperopia (source: National Eye 
Institute) 
Heredity is considered to be an important risk factor for hyperopia. Various 
congenital abnormalities such as Leber's congenital amaurosis, Down syndrome 
and Aarskog-Scott syndrome have also been reported to affect the process of 
emmetropization grossly leading to the development of the condition (24, 25). 
Compared to other refractive errors, hyperopia is associated with greater symptoms 
of discomforts such as headaches, tearing eyes, decreased binocularity and eyestrain 
(26). Vision loss from hyperopia usually results from the development of one of the 
complications of the condition such as amblyopia and is more common among 
children with high degrees of hyperopia during infancy (12). 
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1.3 Astigmatism 
 
In the case of astigmatism, rays of light coming from a distant object are refracted 
to multiple or a line focus instead of a point focus by the eye’s optical system (27, 
28).  
 
Figure 3: Multiple or line focus instead of a point focus of the image in 
astigmatism (source: National Eye Institute) 
 
There are several factors in the school health environment that can contribute to 
the development of astigmatism. Prominent among these include dusty 
environment leading to constant rubbing of the eyes and exposure to ultra violet 
radiation from outdoor activities (27-28). Promotion of behaviors such as regular 
hand washing and reduced exposure to the sun have been shown in some studies 
to reduce the incidence of the condition (28) 
The condition which usually presents together with other refractive errors 
results from an imperfect shape of the cornea or the lens of the eye. The 
symptoms of astigmatism tend to be common to that of other refractive errors 
though can be more severe in certain age groups such as school-age children 
where demand for close work like reading and writing is high. 
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2.0 Treatment 
 
Correction of refractive errors is provided in different forms depending on the type of 
defect, the age of the person and the requirements in terms of work or activity 
performed (29). Management ranges from less complicated methods such as the use 
of corrective glasses and contact lenses to more complicated methods like refractive 
surgery. If detected and corrected in time and by eye-care professionals, a refractive 
error can be prevented from leading to sight-threatening eye conditions like 
amblyopia (29). Recent advancement in technology has led to an increase in the 
available treatment options for the various types of refractive error (30). 
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2.1 Available Treatment Options for Myopia 
 
The aim of correcting myopia is to achieve clear binocular vision without 
compromising on patients' comfort. Available treatment options to achieve this 
include the use of optical corrections (spectacles and contact lens), use of medication 
(Pharmaceutical), refractive surgery and Orthokeratology. 
 
 
2.1.1 Optical Correction 
 
Optical correction of myopia involves the use of either concave spectacles or contact 
lenses to reduce the refractive power of the eye’s optical system (30). 
 
 
 
 
Figure 4: Correction of myopia with concave spectacle lens (source: 
www.iblindness.org) 
The choice of either spectacles or contact lens for the correction of the condition 
depends on a number of factors. These include the age of the patient, the outcome of 
the clinical assessment of the patient’s cornea, patient’s motivation, anticipated 
compliance with prescribed spectacle or contact lens and patient’s economic status. 
Comparatively, spectacles remain the most popular form of optical correction of the 
condition according to a number of studies (31). Despite the widespread use of 
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spectacles for the correction of myopia, a number of studies have found it to be 
associated with an increase in the axial length of the eye resulting in myopia 
progression (32, 33). This association between spectacle correction and myopia 
progression has also been reported to be relatively higher in children corrected with 
single vision spectacle (32, 34, 35). A common treatment strategy currently being 
advocated to help deal with the issue of myopia progression among children 
corrected with single vision lenses is under-correction of the myopic error (36). 
 
 
2.1.2 Refractive surgery 
 
Several surgical methods are available for the correction of myopic refractive error 
but the two main procedures currently used in the treatment of the condition are 
Excimer laser photorefractive keratectomy and laser-assisted in situ 
keratomileuses (37). Excimer laser photorefractive keratectomy involves the use 
of a laser to abrade the central part of the cornea, reducing its power in the 
process. 
 
 
Figure 5: Excimer laser photorefractive keratectomy procedure for the correction of 
myopia (source: www.practo.com/health)
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The procedure based on the result of several studies has a relatively high visual 
outcome with most studies reporting between 48-92% of patients achieving 6/6 
unaided visual acuity (38-40). 
 
 
In laser-assisted in situ keratomileuses (LASIK) refractive surgery, a modified 
microkeratome is used to create a central corneal flap followed by the use of an ArF 
excimer laser to produce a 3mm diameter ablation on the central part of the exposed 
stromal bed (41). 
 
 
 
 
 
 
Figure 6: Lasik surgical procedure for the correction of myopia (source: 
www.iblindness.org) 
LASIK has been reported to be an acceptable refractive surgical technique for the 
correction of refractive error with effective outcomes (42-44) 
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2.1.3 Medical (Pharmaceutical) 
 
Medical treatment of myopia involves the use of cycloplegic agents such as atropine 
to inactivate the ciliary muscle of the eye, reducing the refractive power of the lens in 
the process. Despite a number of published studies reporting a reduction in the 
progression of myopia among children treated with a daily topical administration of 
atropine and cyclopentolate, other studies have associated this treatment option with 
other vision-related adverse effects, allergic reactions and systemic toxicity (45, 46). 
 
2.1.4 Orthokeratology 
 
This method of myopia treatment involves the programmed fitting of a series of 
contact lenses over a period to flatten the cornea of the eye and reduce its refractive 
power. The suitability of this treatment option depends to a large extent on the degree 
of myopia and the shape or integrity of the cornea of patients undergoing the 
procedure. Corneas with greater peripheral flattening are thought more likely to have 
successful central flattening, thus leading to reduced myopia via orthokeratology 
(47). Orthokeratology has also been shown to be more effective in adults compared 
to children (48). 
 
 
2.2 Available Treatment Options for Hyperopia 
 
Like in the case of myopia, correction of hyperopia is aimed at achieving clear 
binocular vision without compromising on patients' comfort. Numerous treatment 
option exists for hyperopia correction. 
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2.2.1 Optical Correction 
 
Among the numerous treatment options for hyperopia correction, optical correction 
with convex spectacle lens or contact lens is the most widely accepted and 
commonly used in the management of the condition by most clinicians. These lenses 
work by increasing the degree to which light from either a distance or near objects is 
bent as they go through the eye, shifting its focus from behind the retina unto the 
retina. 
 
 
Figure 7: Correction of hyperopia with convex spectacle lens (source: 
www.iblindness.org) 
 
 
2.2.2 Refractive surgery 
 
The commonly used refractive surgery procedure for the management of hyperopia 
include Holmium YAG laser thermal keratoplasty, automated lamellar keratoplasty 
(ALK), excimer laser clear lens extraction with intraocular lens implantation and 
spiral hexagonal keratotomy (49, 50). The use of refractive surgery for the correction 
of hyperopia has been found to be more effective in the correction of lower degrees 
of hyperopic errors (<3.00D) (51). The long-term outcome of the various refractive 
surgery procedure for hyperopia has not been established due to limited number of 
studies in that area. 
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Figure 8: Illustration of hyperopia using Figure 9: Illustration of hyperopia 
Holmium YAG Laser (www.dr.maime.com) Using ALK (www.urbaneye.com) 
 
 
2.2.3 Medical (Pharmaceutical) 
 
This treatment option is normally reserved for patients who cannot benefit from more 
suitable methods like a spectacle or contact lenses. It involves the use of mitotic 
agents such as pilocarpine to mimic the accommodative effect of convex lenses 
resulting in the focus of images unto the retina (52, 53). 
 
 
Figure 10: Illustration of the use of Miotic agents (pilocarpine) to mimic the 
accommodative effect of convex lenses in correcting hyperopia (source: 
www.reviewofoptometry.com) 
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2.3 Available Treatment Options for Astigmatism 
 
Available treatment option for the correction of astigmatism includes optical, medical 
(pharmaceutical) and refractive surgery. The type of treatment option considered for 
a particular patient normally depends on the degree of the astigmatic error. 
 
2.3.1 Optical Correction 
 
Toric spectacle and contact lenses are the most commonly used treatment modalities 
for the correction of astigmatism. These lenses which have curvature at different 
angles work to refract parallel rays of light from a distant object to a point focus 
instead of multiple or a line focus, correcting the astigmatic error in the process (54, 
55). 
 
 
Figure 11: Correction of astigmatism with toric spectacle lens (source: 
www.iblindness.org) 
 
Although toric spectacle lenses are a good treatment option for astigmatism of low 
degree, there are studies indicating that they may provide sub-optimal correction for 
the astigmatic error of moderate to a high degree (56). This is because the slightest 
tilt in the way the spectacles sit on a patient’s face affect the refraction of light by 
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various curvature of the spectacle lenses, leading to poor image quality. Most 
studies have however recommended the use of rigid gas permeable toric lenses for 
the correction of moderate to a high degree of astigmatism in patients who can 
tolerate them (55, 57, 58). 
 
2.3.2 Refractive surgery 
 
Due to the limitation associated with the use of spectacles for the correction of 
moderate to a high degree of astigmatism and the inability of most patients to adapt 
properly to rigid gas permeable contact lenses, the use of refractive surgery for 
correction of the condition is becoming popular among patients and clinicians alike. 
The common refractive surgery procedure for the condition include laser-assisted in 
situ keratomileuses (LASIK), toric intraocular lens implantation and photorefractive 
excimer laser surgery. Among these methods, excimer laser surgery has been 
reported by several studies to have the best visual outcomes with most studies 
reporting an uncorrected visual acuity of 20/25 or better in over 90% of eyes, years 
after surgery (59, 60). 
 
 
 
Figure 12: illustration of excimer laser surgery for the correction of astigmatism 
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2.3.3 Significant Refractive error 
 
Refractive error can also be classified based on its effect on vision. According to 
the WHO, refractive error is considered to be significant in adults if the visual 
acuity is less than 6/18 in both eyes while in children, visual acuity of less than 
6/12 in both eyes is indicative of significant refractive error warranting 
appropriate and timely management. In practice, however, significant refractive 
error is said to be present in the patients if he/she is given the correct spectacle 
and he/she wears them (29, 61, 62). 
 
 
3.0 Epidemiology of Refractive Error 
 
Refractive error is considered an issue of public health concern. According to 
recent studies and WHO report, refractive errors remain the major cause of visual 
impairment and the second leading cause of vision loss across the world. Despite 
the relatively easy treatment options available for the management of the 
condition, it is estimated that over 101.2 million people across the world are 
visually impaired and 6.8 million people are blind from the condition due to lack 
of assessing to appropriate treatment (23, 63, 64). An uncorrected refractive error 
has also been reported in a number of studies to be associated with limitations in 
vision-related tasks and a significant decrease in the quality of life of those 
affected (65, 66). The increasing number of studies reporting an improvement in 
the vision-related quality of life following the correction of refractive error 
among children and adult's population further demonstrates the need to prioritize 
the condition (67, 68). 
The prevalence of refractive error varies globally depending on the geographical 
location, ethnicity, sex and age (69, 70). The prevalence of myopia has been 
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shown by a number of studies to be higher in East Asia with hyperopia having a 
higher prevalence in Europe and some western countries (1, 71-73) 
The prevalence of refractive errors is reported to be relatively lower in Africa 
compared to East Asia and Europe. Studies that have been done in Nigeria (74), 
Ethiopia (75), South Africa (1), Uganda (76) and Ghana (77) have reported the 
prevalence of myopia to be 4.4%, 2.6%, 4.0%, 4.4%, and 1.7% respectively. 
There are some controversies however regarding this low prevalence of the 
condition in Africa due to the limited number of studies and the possibility of 
underestimation of the prevalence due to lack of detection of the condition 
among people in low-income settings with limited access to eye care services. 
 
 
While a systematic review in 2018, for example, found the prevalence of myopia 
in adults to be higher in East Asia compared to Europe and Africa, the prevalence 
of the condition among children was relatively higher in Africa compared to 
South- East Asia as shown in table 1.0. The result of this systematic review 
agreed with the reported high prevalence of myopia among adults in South East 
Asia and low prevalence among the adult population in Africa but differed from 
the well documented high prevalence of the condition in East Asian children and 
low prevalence in African children (64). It is, however, important to acknowledge 
that the review only included prevalence studies that met their inclusion criteria 
instead of all prevalence studies (64). The authors in their discussion also 
admitted that “it difficult to explain the low prevalence of myopia in South-East 
Asian children, but it seems that one of the reports from Nepal (78) with a very 
large sample size decreased the estimated prevalence of myopia in that region. 
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3.1 Estimated Pool prevalence (EPP) of myopia, hyperopia, and astigmatism 
in children and adults by WHO regions 
 
Table 1: EPP of myopia, hyperopia and astigmatism in children and adults by WHO 
regions (64). 
 
 
4.0 Magnitude of Uncorrected refractive error among school children 
 
Over the past decade, Refractive Error in Children (RESC) surveys conducted in 
different countries across the world have shown an increasing prevalence of 
uncorrected refractive error among school-age children (1, 79-82). Currently, it is 
estimated that over 12.8 million children between the age group of 5-15 years in the 
world have uncorrected refractive error leading to visual impairment (83). The global 
prevalence of uncorrected refractive error among children in this age group is also 
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reported to be 0.96%. A significant number of these children are found in LMIC like 
China, India and some parts of Africa. The prevalence of the various type of 
refractive error among children between the ages of 5-15 years has varied among 
studies. The prevalence of myopia, hyperopia, and astigmatism have ranged from 
3%- 35%, 0.4%-17% and 2.2%-34% depending on the cut-off used as definitive of 
refractive error and the region or setting in which studies are conducted (64). 
 
 
5.0 Economic/Social Impact of Uncorrected refractive error among children 
 
Uncorrected refractive error has been shown in a number of studies to have a 
significant economic impact (65, 80, 84). According to a recent study, uncorrected 
refractive error in children and young adults account for an annual global economic 
loss of $269 billion (65). The impact of uncorrected refractive error on the socio-
economic status of those affected is 2-fold. While poverty and inability to access 
treatment has been found to drive the increasing prevalence of the condition, the 
visual impairment resulting from uncorrected refractive error also negatively impact 
the educational and employment opportunities of children and people affected. This 
negative impact of uncorrected refractive error on the socio-economic status, 
academic performance, overall quality of life of children and its potential to lead to 
sight-threatening eye conditions like amblyopia is well documented in a number of 
studies (65, 84, 85). 
Given the increasing prevalence of visual impairment due to uncorrected refractive 
errors in children and the simplicity of treatment, the introduction of vision 
screening programs that aim to detect and treat the condition among school-aged 
children has been made one of the priorities of the WHO’s Vision 2020 initiative 
(86) 
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6.0 Description of Intervention (School Vision screening programs) 
 
School screening programs have become popular in many developed countries as a 
way of identifying children with eye conditions such as refractive error so early 
intervention can be made (87). In most of these developed countries, school vision 
screening programs are incorporated into the health care delivery system (88). For 
example, countries like the United States, United Kingdom, and Sweden have 
successfully incorporated vision screening program into their educational system 
allowing children to receive visual acuity screening either before or after school 
entry (89-91). The situation, however, is different in LMIC where factors such as 
limited funding to support the programs and lack of stakeholder commitment prevent 
children from benefitting from early detection of eye conditions which potentially 
can impact their academic performance. 
 
6.1 Policies on School Vision Screening 
 
There exists considerable variation in the guidelines, policies, and requirements for 
vision screening across the world (92). Important areas of variation include; visual 
function to be assessed as part of vision screening programmes and the particular 
tests to be used to assessed those visual functions, the type of personnel to be used 
for vision screening, the ideal age of children eligible for vision screening, the 
frequency of vision screening, the criteria for referral of children for further 
assessment and most importantly what additional intervention should be provided as 
part of vision screening programs (free spectacles, education, teacher incentive, etc.) 
(92). 
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6.1.1 Legislations on School vision screenings 
 
While countries such as the United States have legislation in place ensuring 
mandatory screening of all children of school going age for eye conditions that can 
potentially affect their academic performance prior to school entry, most LMIC do 
not have such legislation. Vision screenings in these countries are therefore 
conducted on an ad hoc basis by various health care professionals including 
optometrists, medical practitioners, ophthalmologist and orthoptists in both the 
government and private sector (92). This lack of legislation to regulate vision 
screening programs in these LMIC has had a negative effect on the development of 
the program especially in countries where the commitment of eye care 
professionals in the private and government sector is lacking (93). 
 
 
6.1.2 : Age for Vision screening 
 
The ideal age at which vision screening is recommended has been the subject of 
debate for most countries that have made efforts to introduce national vision 
screening programs (94). While some countries have focused on vision screening 
for preschoolers with the aim of identifying children with eye defects that can lead 
to more serious conditions like amblyopia and strabismus, other countries advocate 
for vision screening among children already enrolled in schools as the chances of 
detecting eye conditions such as refractive error that may have an effect on their 
academic performance is high (94, 95). 
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6.1.3 : Personnel for School Vision screening 
 
In most countries where school vision screening is either part of the national eye 
health program or conducted by private organizations, eye care professionals 
including optometrists, ophthalmologist, orthoptist and ophthalmic nurses are usually 
used as the vision screening personnel. Unfortunately, due to a limited number of 
these eye care professional in LMIC, the use of other trained personnel such as 
ophthalmic assistants and teachers have become popular in recent years. Several 
studies have investigated the effectiveness of using other personnel such teachers for 
school vision screening and the result of these studies have indicated that this may be 
a more cost-effective method of ensuring the sustainability of school vision screening 
programs in countries or setting with few numbers of trained eye care professionals 
(96-98). 
 
6.1.4 Additional intervention (Spectacle Provision as part of Vision Screening) 
 
Despite spectacle provision being commonplace in most school vision screening 
program, it is important to acknowledge that school screening is an entry level 
procedure and provision of spectacles is only an extension of the program (98). 
There is some level of evidence indicating that the provision of free spectacles as 
part of school vision screening programs can have a positive effect on program 
outcome in terms of improved academic performance among children, there still 
exist a lot of debate on its effectiveness in reducing the proportion of children with 
uncorrected refractive error in the long term. Some studies have reported a low level 
of compliance with the use of spectacles provided as part of school vision screening 
programs, questioning the cost-effectiveness of this approach in school vision 
screening programs. 
41 | P a g e  
7.0 Systematic reviews of the effectiveness of school screening in reducing 
children with uncorrected refractive error/ relevance of the current review 
To the best of our knowledge, there exists no systematic review that has assessed the 
effectiveness of school vision screening programs in reducing children with 
uncorrected refractive error in LMIC. In light of this, a systematic review that aims 
to answer the important question; Are school vision screening programs effective in 
reducing children with uncorrected refractive error in LMIC? is deemed appropriate 
and is the focus of this systematic review. 
 
8.0 Summary and Conclusion of the Literature Review 
 
There is an increase in the prevalence of uncorrected refractive error among school-
age children in recent times. School vision screening has been advocated for by 
various national and international organizations to help deal with the issue. There 
exist a lot of debate however on the effectiveness of the program in the LMIC 
settings where the limited resources available cannot be afforded to be wasted on 
health care interventions that do not work in the long term. This has made a study 
assessing the effectiveness of school vision screening programs necessary. 
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Abstract 
 
Background: The prevalence of uncorrected refractive error among school-age 
children is on the rise with a detrimental effect on academic performance and socio-
economic status of those affected. School vision screening appears to be an effective 
way of identifying children with uncorrected refractive error so early intervention can 
be made. Despite the increasing popularity of school vision screening programs in 
recent times, there is a lot of debate on its effectiveness in reducing the proportion of 
children with uncorrected refractive error in the long term especially in settings where 
resources are limited. 
Objective: To assess the effectiveness of school vision screening programs in reducing 
children with uncorrected refractive error in LMIC. 
Search Methods: To identify studies suitable for this systematic review, a 
comprehensive and systematic search strategy was employed. We searched various 
databases and the search was restricted to articles published in English. 
We included RCTs, cross-sectional studies, case-control studies, and cohort studies. 
Participants included school children who had undergone vision screening as part of 
school vision screening programs in the LMIC setting and found to have a refractive 
error. 
Two independent reviewers screened the result of the search output and performed a 
full-text review of the search result to identify papers that met the pre-defined inclusion 
criteria. Data extraction and risk of bias assessment for the included studies was 
performed by the two independent reviewers and discrepancies were resolved by 
consensus and through consultation. The certainty of the evidence was assessed using 
the GRADE approach. 
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Main Result: We found thirty relevant studies conducted in ten different countries that 
answered our review questions. Our review showed that school vision screening may 
be effective in reducing the proportion of children with an uncorrected refractive error 
by 81% (95% CI: 77%; 84%, moderate certainty evidence), 24% (95% CI: 
13%; 35%, moderate certainty evidence,) and 20% (95% CI: 18%; 22%, moderate 
certainty evidence) at two, six, and more than six months respectively after its 
introduction. 
 
 
 
 
 
 
 
Our review also suggest that school vision screening may be effective in achieving 
54% (95% CI: 25%; 100%, moderate certainty evidence), 57% (95% CI: 
46%; 70%, low certainty evidence), 38% (95% CI: 29%; 51%, moderate certainty 
 
evidence) and 41% (95% CI: 24%; 68%, low certainty evidence) level of spectacle 
wear compliance among school children at less than three months, at three months, at 
six months and at more than six months respectively after its introduction. 
 
Our review further found moderate to high certainty evidence indicating that school 
vision screening together with the provision of spectacles may be relatively cost-
effective, safe and has a positive impact on the academic performance of children. 
Conclusion: Result of this review shows that school vision screening together with 
the provision of spectacle may be a safe and cost-effective way of reducing the 
proportion of children with uncorrected refractive error with a long-term positive 
impact on academic performance of children. Most of the studies included in this 
review were however conducted in Asia and the applicability of this finding to 
countries in other regions especially those outside the LMIC circle is not clear. 
Keywords: Refractive error, low- and middle-income countries, vision screening 
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1.0 Background 
 
Refractive error is the most common cause of visual impairment especially among 
children according to recent studies and the WHO’s report (63). Globally, it is 
estimated that 43% of visual impairment can be attributed to refractive error (62). 
Refractive error is an intrinsic optical defect of the eye in which parallel rays of 
light coming from optical infinity are focused either in front or behind the retina 
with accommodation fully relaxed (16, 17). Without timely treatment, refractive 
errors due to the poor image they present to the retina can lead to more serious 
eye conditions like amblyopia (29, 87). 
School vision screening program has been developed in different countries and 
settings to detect the condition especially during the assumed critical period of visual 
development where early treatment can prevent more complicated conditions like 
amblyopia (87-88). Most school vision screening programs are however 
concentrated in developed countries where they are mostly provided as part of the 
healthcare system by the government or incorporated into the educational system 
(89). In LMIC however, the situation is different. Despite the WHO’s advocate for 
the incorporation of vision screening programs into the health care delivery system 
of these countries as part of it Vision 2020 initiative, lack of government 
commitment, inadequate infrastructure, funding and a limited number of health care 
professionals continue to be a major hindrance (99, 100). The lack of government’s 
commitment and support for the introduction of vision screening programmes in 
most LMIC have mainly been attributed to the lack of evidence to support the 
effectiveness of these programmes in areas where they have already been introduced 
(89, 101) Few studies that have sought to assess the effectiveness of these programs 
have also looked mainly at vision screening programs in developed countries (89). 
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In January 2018, a revised Cochrane review examined vision screening for 
correctable visual deficit due to a refractive error in school-age children and 
adolescents (13). In their conclusion, the authors acknowledged that despite the 
evidence from China (where five out of the seven studies included in their review 
were conducted) suggesting that vision screening may be effective in improving 
spectacle wearing and educational outcome, the applicability of the finding to other 
parts of the world where few or none of the studies that met their inclusion criteria 
were conducted was not clear (13). A recommendation for more studies to be 
conducted in these areas was made. The Cochrane review, however, included only 
RCTs making other non-RCTs that possibly provides the best opportunity at present 
to evaluate the effectiveness of the programs in these areas' ineligible for inclusion. 
Considering the fact that only a few RCTs have assessed school vision screening in 
LMIC, it has become necessary for a review that examines all the available 
evidence at present regardless of the study type to be conducted. The current 
review, therefore, hopes to achieve this by including both RCTs and non- RCTs 
evaluating the effectiveness of the programs in the context of LMIC. 
 
 
2.0 Objective 
 
To evaluate the effectiveness of school vision screening programs in LMIC to 
reduce the proportion of children with uncorrected refractive error. 
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3.0 Methods 
 
This was a systematic review evaluating the effectiveness of a health care 
intervention. Reporting of the finding was guided by the PRISMA guidelines (14) as 
shown in appendix 5.4. 
 
3.1 Criteria for considering studies for this systematic review 
 
3.1.1 Types of Studies 
 
We included the following study design type in this review; RCTs, cross-sectional 
studies,case-control studies, and cohort studies. 
 
 
3.1.2 Type of Participants 
 
We included children who had undergone vision screening as part of school vision 
screening programs in the LMIC setting and found to have a refractive error. 
Participants with other ocular pathologies accounting for poor vision were excluded 
from this systematic review. 
 
 
3.1.3 Types of outcome measure 
Primary Outcome 
The proportion of children with uncorrected or sub-optimally corrected refractive error. 
 
 
 
Secondary outcomes 
 
 Long term effect of school screening programs on the academic 
performance of participants 
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 The adverse effect of school vision screening programs (i.e. anxiety 
from interviews, misdiagnosis, symptoms associated with the use of 
prescribed spectacles, etc.) 
 Cost-effectiveness of school vision screening programs. 
 
 Influence of school vision screening programs on compliance with 
spectacle wearing. 
 
 
3.2 Search methods 
 
3.2.1 Identification of studies 
 
To identify studies suitable for this systematic review, a comprehensive and systematic 
search strategy was used. A search of eligible articles was performed using keywords, 
truncated terms, the Boolean operator and Medical Subject Heading (MESH) terms. 
The search was restricted to articles published between 1980 and 2018 and the search 
was done from January to August 2018. The following electronic database was 
searched; PubMed, Cochrane Central Register of Controlled Trials (CENTRAL) 
which contains the Cochrane Eyes and vision Trial Register, the Cochrane Library, 
Medline (1980-2018), CINAHL, Academic Search Premier, Web of Science, the 
WHO’s Library Information System, Africa-Wide and Scopus. Combined search of 
MESH terms, titles and abstracts were used for each step of the search. The search was 
restricted only to articles written in English. Since this systematic review seeks to 
summarize evidence on the effectiveness of school vision screening programs to 
reduce the proportion of children with uncorrected refractive error, studies involving 
vision screening programs that targeted subgroup population such as children with 
specific ocular pathologies other than a refractive error (e.g. congenital glaucoma, 
congenital cataract, etc.) were excluded. 
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Filters were also used during the search for articles to ensure that only studies in LMIC 
were included in this systematic review. Countries names and regional names were 
used in the electronic search. This was to ensure that both country-specific records and 
records indexed by a regional term such as ‘West Africa’ were included in this 
systematic review. In instances where a country has English and local name, both 
names were used to increase the sensitivity of the electronic search in identifying all 
the relevant articles for the review. Efforts were made to identify unpublished studies, 
government reports, theses, dissertation and conference papers by searching google 
(including google scholar) and WorldCat. Additionally, the reference list of all the 
included studies was searched for any articles that may have been missed during the 
initial search. A detailed description of the search strategies used is included in 
appendix 5.1 
 
 
3.3 Data collection and analysis 
 
3.3.1 Selection of Studies 
 
Selection of studies to be included in this systematic review went through three 
phases involving two independent reviewers. In the first phase, two reviewers; 
Abraham Opare (AO) and Leila Abdullahi (LA) checked the electronic search result 
and selected all studies that made reference to refractive error, myopia, hyperopia, 
astigmatism, and vision screening. Any identified article that was found to be clearly 
irrelevant at first glance was excluded. In the second phase of the selection process, 
the two independent reviewers (AO and LA) screened the titles and abstracts of 
studies identified to be relevant in the first phase to determine their eligibility for 
inclusion in the systematic review. The full text was obtained by AO for studies that 
had no abstract. In the third and final phase of the selection process, the two 
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reviewers (AO and LA) performed a full-text review of all articles whose abstracts 
were found to be relevant in the second phase. The full-text review was also done for 
articles whose abstract failed to provide a clear description of the study. Using the 
study’s inclusion and exclusion criteria, the two reviewers (AO and LA) finally 
selected the studies to be included in the systematic review. In instances where we 
were unable to come to an agreement on whether a paper was eligible for inclusion, 
an arbitrator Colin Cook (CC) who is an expert in the field was consulted. The search 
and selection of articles for this systematic review were summarized using the 
PRISMA flow chart. The characteristics of all included studies in this review and the 
reason for exclusion of studies has been well documented using tables. 
 
 
3.3.2 Data extraction and management 
 
Data from the selected studies were extracted using a standardized Cochrane 
collaboration data extraction form that was modified to suit this systematic review. 
(Attached as Appendix 5.2). Initial piloting of the data extraction form was done to 
ensure uniformity among the two independent reviewers (AO and LA). Where it was 
possible, we extracted information on study participants including their age, sex, 
school grade and number of participants, study setting (city and country), additional 
intervention (spectacle provision, health education, teacher incentive etc.) and type of 
outcome measure (spectacle compliance, cost of screening, improvement in 
academic performance etc.). Indicators of the severity of refractive error such as the 
visual acuity in the worse eye were also extracted. Additionally, any data deemed to 
be an appropriate indicator of the effectiveness of a school vision screening program 
such as the number of children who benefited from spectacle correction 
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of their refractive error, compliance with wearing of spectacles provided as part of 
vision screenings, etc. was also extracted. 
 
 
3.3.3 Assessment of risk of bias in included studies 
 
Assessment of risk of bias for prevalence studies was done using the Hoy criteria tool 
(attached as appendix 5.3a). A 10-point scale was applied to all the cross-sectional 
studies to assess both their internal and external validity. A score of 8 or more “yes” 
in the 10-point scale was considered a low risk of bias, 6-7 score, moderate risk of 
bias and 5 or less “yes” high risk of bias. For RCTs investigating the effectiveness of 
school vision screening programs in reducing the proportion of school children with 
uncorrected refractive error, risk of bias was assessed using the Cochrane Effective 
Practice and Organization of Care (EPOC) tool (Attached as appendix 5.3b). For 
each study, we independently reported our judgment of the risk of bias as either 
being low, high or unclear and cases of disagreements were resolved by an arbitrator 
(CC) who is an expert in the field. Where deemed necessary, the funnel plot was 
used to check for publication bias across the included studies. 
 
 
3.3.4 Subgroup analysis 
 
When and where appropriate, subgroup analysis was done to determine the effect of 
the definition used as an indication of spectacle compliance in the various studies on 
the pooled spectacle compliance. 
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3.3.5 The measure of the intervention effect. 
 
We expressed the result of each study which assessed our primary outcome as a risk 
difference with the corresponding 95% confidence interval (CI). Compliance with 
spectacle wearing was expressed as proportions with the corresponding 95% CI. We 
grouped studies based on the follow-up period, study design and definition used as 
an indication of spectacle compliance to get reasonable results for an overall 
estimate of effect. 
 
3.3.6 Dealing with missing data 
 
We did not have cases of missing data in this systematic review and therefore made 
no contact with primary study authors for missing data. 
 
 
3.3.7 Heterogeneity assessment 
 
Studies included in this systematic review were checked for heterogeneity by 
examining their characteristics (study design, population, setting, etc.) and risk of 
bias. The Cochran’s Q-test and the Higgins Chi-square test for heterogeneity was 
used to statistically explore any heterogeneity among the included studies using an 
alpha level of 10%. Heterogeneity was considered as significant if the Chi-square 
was above 50%. 
 
3.3.8 Data synthesis and analysis 
 
Analysis of quantitative data was done using RevMan 5.3 software. Data from 
studies with a low or medium risk of bias found to be relatively similar in terms of 
outcome, follow-up period and participants were pooled together in a meta-analysis 
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using the random-effect model. The measure of effect used as an estimate for the 
reduction in the proportion of children with uncorrected refractive error after the 
introduction of school vision screening was risk difference. This was calculated by 
subtracting the proportion of children with uncorrected refractive error prior to 
exposure to school vision screening from the proportion of children with uncorrected 
refractive error post-exposure to school vision screening. In all instances, the 95% CI 
was presented. Additionally, the STATA 14 statistical package was used to obtain 
estimates of the proportion of children with uncorrected refractive error where 
necessary. In cases where statistical analysis of data was not possible, a narrative 
technique was employed in presenting the result. A subgroup analysis was done 
where deemed necessary to examine the impact of the definition used as an 
indication of compliance with spectacle wear on the size and direction the effect. 
 
 
3.3.9 Quality of evidence 
 
The quality of the evidence presented in this systematic review was assessed using 
the GRADE approach. Based on the level of confidence we have in the outcome, we 
graded the evidence as either low, moderate or high certainty evidence. 
We judged the effect estimate in this review as high certainty evidence if we were 
very confident the true effect lies close to that of the estimated effect. Estimates 
were judged as moderate certainty evidence if we were moderately confident that 
the true effect lies close to that of the estimate of effect. In instances where had very 
little confidence that the true effect lies close to an effect estimate, that estimate was 
judged as low certainty evidence (15). 
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4.0 Results 
 
4.1 Search Result 
 
Our electronic search identified 2101 articles. After removal of duplicates, 1583 
articles remained for screening. 1532 articles which were found to be irrelevant to 
this review were excluded leaving 51 articles for full-text review. Using the 
predefined inclusion and exclusion criteria as a guide, 18 articles were excluded 
based on reasons given in table 3, and full text for 3 articles could not be obtained 
(table 4). Thirty (30) articles which met the inclusion criteria were included in this 
review. The processes involved in the search, screening, and selection of articles for 
inclusion in this review is summarized using the PRISMA flow diagram (figure 13) 
 
4. 2 PRISMA Flow Diagram 
 
Figure 13: PRISMA flow diagram 
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4.3 Description of Included studies 
 
Thirty articles retrieved from the electronic search met our inclusion criteria. Out of 
these, six were cluster RCTs with schools as clusters (11, 102-106), four were RCTs 
with randomization done at the individual level (107-110), three were non-RCTs 
(111-113), six were cohort studies (10, 114-118) and eleven were cross-sectional 
studies (119-129) 
 
Twelve of the eligible studies were conducted in India (10, 108, 112, 113, 116, 117, 
 
121-124, 127, 128), eight were conducted in China (102-107, 109-111). One study 
was conducted in Chile (129), one was done in Tanzania (11), one was conducted in 
South Africa (115), one was from Mexico (107), one was conducted in Oman (119), 
one was conducted in Nepal (120), one was done in Thailand (129) and one was 
conducted in Botswana (125). All the included studies enrolled both males and 
females', children. A detailed description of all included studies is provided in the 
table 
2. A summary of countries where selected studies were conducted is also given in 
 
figure 14 
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Table 2: Characteristics of Included studies 
 
Study ID Study Design Population /Setting (Location and 
social context) 
Total no. 
enrolled 
Sex/Age (Years) Main Intervention if applicable Duration of 
participation 
Wedner, 2008 Cluster 
randomized trial 
School children were drawn from 37 
senior secondary schools in Dar es 
Salaam 
6904 Male and female, 
aged 11-25 years 
free spectacles 6-month period 
Ma, 2014 Cluster 
randomized trial 
Primary school children in fourth and 
fifth grades in Western China 
3177 Male and female, 
mean age 10.5years 
free spectacles or voucher for spectacle 8-month period 
Ma, 2015 Cluster 
randomized trial 
Primary school children in fourth and 
fifth grades in Western China 
3177 Male and female, 
mean age 10.5years 
free spectacles or voucher for spectacle 8-month period 
Yi, 2015 Cluster 
randomized trial 
School in schools at Shanghai and 
Suzhou/Wuxi in China 
4376 Male and female, 
aged 10-12 years 
free spectacles +Educational intervention 6-month period 
Morjaria, 2017 Non-inferiority, 
double-masked, 
randomized 
clinical trial 
School children in government 
secondary schools in urban and peri-
urban areas surrounding Bangalore in 
Karnataka State in India 
23345 Male and female, 
aged 11-15 years 
less expensive ready-made spectacles 3-4-month period 
Congdon, 2011 A randomized, 
controlled trial. 
School children in years 1 and 2 of all 
20 junior and senior high schools in 3 
rural townships in Guangdong, China 
11423 Male and female, 
aged 12-17 years 
an educational intervention to promote spectacle 
purchase 
6-month period 
Zeng, 2009 Randomized, 
double-blind, 
clinical trial. 
Junior high school students from urban 
Guangzhou, China 
4607 Male and female, 
aged 12-15 years 
Ready-made spectacles 1-month period 
Zhou, 2017 a randomized, 
double-masked 
non-inferiority 
trial 
School children in grades 7 and 8 (in 
nine Chinese secondary schools 
9889 Male and female, 
aged 12-15 years 
Ready-made spectacles, rural refractionist, Self- 
refraction 
2 Month period 
Wang, 2017 cluster 
randomized, 
investigator-
masked, 
controlled trial 
School children from primary schools 
in 9 counties in Guangdong and 
Yunnan provinces, China 
10,234 Male and female, 
aged 9-12 years 
Vouchers exchangeable for free glasses (Free Glasses 
group) 
Vouchers exchangeable for free glasses + $15 upgrade 
(Free + $15 Upgrade group) 
Vouchers for free glasses+ $30 upgrade (Free + $30 
Upgrade group) 
6-month period 
Ma, 2018 cluster 
randomized,in
vestigator-
masked, 
controlled trial 
School children in grades 4 through 6 2613 Male and female, 
aged approx. 10-12 
Early Referral to a local vision Centre for refraction and 
free glasses from September to October of screening to 
December 2014-February 2015) of referral 
About 6-month 
period 
Kaey,2010 prospective 
clinical trial 
Students in 5 junior high schools in 
Guangzhou, China 
428 Male and female, 
aged 12-15 years 
Provision of new spectacles as part of school screening 
program 
1-month period 
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Narayanan,2018 experimental 
study 
School children in 11 government 
schools in and around 
Chennai, India 
8,442 Male and female, 
aged 13-15 years 
Conventional school screening protocol + 23 step 
intervention involving 1. Awareness of eye and vision 
care to all children, spectacle use and benefit, the 
incentive for use of spectacle (Interventions were 
broadly classified as frame-and-fit-related solutions, 
solutions pertaining to education and motivation, and 
conduct of the screening.) 
12-month period 
Priya, 2014 prospective, non- 
randomized 
control study 
School children in primary schools in 
India 
80463 Male and female, 
aged 6-17 years 
All Class Teacher N/A 
Von- 
Bischhoffshausen 
, 2014 
Cohort study School children in schools in the 
city of Concepcion, Chile 
270 Male and female, 
aged 4-9 years 
Spectacles as part of a school vision screening program 12-month period 
Gogate, 2013 Cross-sectional 
follow-up study 
School children in rural secondary 
schools in Pune District of India 
1035 Male and female, 
aged 8-16 years, 
mean age (12.1 
years) 
Spectacles as part of a school vision screening program 12-month period 
Congdon,2008 A prospective 
study (cohort) 
School children from 1 rural and 12 
urban secondary schools in Umtata in 
the Eastern Cape Province of South 
Africa 
8520 Male and female, 
aged 6-19 years 
Spectacles as part of a school vision screening program 4-11 Month 
period 
Shukla, 2018 cross‑sectional 
study 
Primary school children from 
government 
schools in India 
6056 Male and female, 
aged 7-10 years 
Spectacles as part of a school vision screening program About 6 Month 
period 
Castanon, 2006 prospective 
cohort 
study 
Primary and secondary school from 
schools in Oaxaca, Mexico. 
634 Male and female, 
aged 5-18 years 
Spectacle provision as part of a school vision screening 
program 
18 Month period 
Rewri,2013 prospective 
cohort 
study 
Students in standard 6th to 12th in a 
rural area of northern India 
7411 Male and female, 
aged 10-19 years 
Spectacles provision as part of a school vision screening 
program 
2 Month period 
Aldebasi,2013 cross-sectional 
descriptive study 
The primary school children l of 
Qassim Province who has been 
prescribed the spectacles during 
the school year 2010-2011. 
631 Male and female, 
aged 7-13 years 
Spectacle prescription as part of the school vision 
screening program 
6-month period 
Limburg, 1995 cross-sectional 
descriptive study 
Middle school children in New Delhi, 
India 
46672 Male and female, 
aged 10-15 years 
N/A N/A 
Sumana, 2015 cross-sectional 
descriptive study 
School going children in Salagame, 
Hassan in India 
391 Male and female, 
aged 9-16 years 
School eye screening program 6-month period 
Rustagi,2012 intervention 
study 
middle and secondary government 
schools' children 
in the northwest district of Delhi 
1123 Male and female, 
aged 11-18 years, 
mean age 
14.25 
School eye screening program + provision of 
prescription for spectacles 
8-month period 
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Limburg, 1999 Retrospective 
Cohort study 
 
primary and middle schools' children 
from 61 districts in 
India 
5.39 
million 
Male and female, 
aged 6-15 years 
School vision screening + Provision of free spectacles 60-month period 
(5yrs) 
Khandekar, 2008 cross-sectional 
descriptive study 
School children in 2 regions in 
Central India 
77 Male and female, 
age not reported 
School screening vision + Provision of free 
spectacles 
3 to 4-month 
period 
Bhandari, 2016 population-
based, cross-
sectional study 
school children 
within schools within Chitwan district 
in Nepal 
170 Male and female, 
aged 7-16 years 
School screening vision + Provision of free 
spectacles 
12-month period 
Pavithra, 2014 cross-sectional 
study 
government school children in both 
rural and urban field practice areas of 
a medical college in Bangalore 
1378 Male and female, 
aged 7-15 years 
School screening vision + Provision of free 
spectacles 
3-month period 
Bhatt, 2017 cross-sectional 
study 
School children in Rohtak, Haryana, 
India 
200 Male and female, 
aged 6-15 years 
School screening vision + Provision of free 
spectacles 
3 Month period 
Tengtrisorn, 2009 cross-sectional 
study 
Primary school children from 11 
schools in Nakhon Hatyai municipality, 
Songkla province-southern Thailand 
1900 Male and female, 
aged 6-12 years 
School vision screening 
program 
11 Month period 
McCormick, 2018 cross-sectional 
study 
School children screened across 49 
schools in Goodhope district in the 
Southern region of Botswana 
300 Male and female, 
median age 15 years 
School screening vision + Provision of free 
spectacles 
3-4 Month 
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Figure 14: Countries where selected studies were conducted 
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4.4 Characteristics of excluded studies 
 
Eighteen studies which did not meet the pre-defined inclusion criteria were excluded 
from this review. Table 3 gives a detailed description of the excluded studies and the 
reasons for their exclusion. 
Table 3: Characteristics of Excluded studies 
 
Author, Year Reason for Exclusion 
Odedra, 2008 Not the outcome of interest 
Rono, 2018 Not the outcome of interest 
Noma, 2012 Not the outcome of interest 
Sudhan, 2012 Not the outcome of interest 
Zhang, 2009 Not the outcome of interest 
Khandekar, 2009 Not the outcome of interest 
Chang, 2017 Not the outcome of interest 
Kaur, 2016 Not the outcome of interest 
Diao, 2016 Not the outcome of interest 
Ondrejkova, 2013 Not the outcome of interest 
Arif, 2014 Not the outcome of interest 
Ajuwon, 1996 Not the outcome of interest 
Esteso, 2007 Not the outcome of interest 
Santos, 2011 Non-English publication 
Frick, 2009 Cost-effectiveness assessed using a hypothetical school vision screening 
program (modeling) rather than through a primary study. 
Frick, 2009 Cost-effectiveness assessed using a hypothetical school vision screening 
program (modeling) rather than through a primary study. 
Shaik, 1992 Not the outcome of interest 
Khandekar, 2013 Not the outcome of interest 
Angell,2018 Wrong Population 
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4.5 Characteristic of studies awaiting assessment 
 
Three studies for which full text could not be obtained are currently awaiting 
assessment. We have already contacted the authors of these three studies via 
email and we are waiting for their response. Once full text for these studies are 
obtained, information relevant to this systematic review will be abstracted and 
this will be taken into consideration in the presentation of the final result of this 
review. Table 4 below gives a summary of these studies.  
Table 4: Characteristics of studies awaiting full text 
 
Author, Year Title Outcome assessed Comment 
 
Bagchi, 2008 
 
Vision screening programs among school 
children--evaluation of the outcome in a 
selected urban locality. 
 
profile of the visual acuity status, refractive 
error and other ocular morbidities and to 
assess the performance at different stages 
following a vision screening program in 
school 
 
The author 
contacted via 
email for full- text 
paper 
Glewwe, 2016  
A better vision for 
development: Eyeglasses and academic 
performance in rural primary schools in China 
 
Effect of spectacles provided via a school vision 
screening program on the academic 
performance of the student and the cost-
effectiveness of spectacle provision as part of a 
school vision screening program 
 
The author 
contacted via 
email for full- text 
paper 
Yabumoto,2009 Factors Associated with Spectacles-Use 
Compliance in a Visual Screening Program for 
Children From Southern Brazil. 
Acceptance and factors related to the 
spectacle- use compliance in low-income 
South Brazilian children, and its effect on 
scholar activities performance. 
 
The author 
contacted via 
email for full- text 
paper 
 
 
 
4.6 Risk of bias assessment (RCTs and non-RCTs) 
 
Risk of bias for RCTs and non-RCTs were assessed using the Cochrane Effective 
Practice and Organization of Care (EPOC) tool. A summary of the risk of bias 
assessment for RCTs and non-RCTs is shown in Table 5 and figure 15. 
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4.6.1 Allocation (Selection bias) 
 
Nine studies (11, 102, 103, 106-111) were judged to have a low risk of selection 
bias (random sequence generation). Three studies (104, 105, 112) were judged to 
have an unclear risk of selection bias (random sequence generation). 
With the exception of one study, (112) which was judged to have an unclear risk 
of selection bias (Allocation concealment), all the other RCTs and non-RCTs 
were judged to have a low risk of selection bias (Allocation concealment) 
 
4.6.2 Blinding (Detection and performance bias) 
 
We judged ten studies (11, 102-106, 108-111) to have a low risk of performance 
bias while two studies (107, 112) were judged to have an unclear risk of 
performance bias. 
Low risk of detection bias was the judgment for nine studies (102, 103, 105, 106, 
108-111) while three studies (11, 104, 115) were judged to have an unclear risk of 
detection bias. 
 
4.6.3 Incomplete Outcome data (Attrition bias) 
 
Risk of attrition bias was judged to be low for all the twelve RCTs and non-RCTs 
(11, 102-112). 
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4.6.4 Selective reporting (Reporting bias) 
 
Six studies (11, 102-105, 108, 110, 112) were judged to have a low risk of reporting 
bias, three studies, (102, 103, 106) were judged to have an unclear risk of reporting 
bias and three studies (107, 109, 111) were judged to have a high risk of reporting 
bias. 
 
4.6.5 Baseline Imbalance 
 
Assessment of baseline imbalance was done for only cluster RCTs. This was found 
to be low for four cluster RCTs (102-104, 108) and unclear for two cluster RCTs (11, 
105) 
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Table 5: Risk of Bias Assessment for Randomized and Non-Randomized control trials 
 
Study ID Random 
Sequence 
Generation 
(Selection 
bias) 
Allocation 
Concealment 
(Selection 
bias) 
Blinding of 
participants 
and personnel 
(Performance 
Bias) 
Blinding of 
outcome 
assessment 
(Detection bias) 
Incomplete 
outcome data 
(Attrition bias) 
Selective reporting 
(Reporting Bias) 
Baseline 
imbalance 
(cluster 
RCTs only) 
Are 
the 
study 
results 
valid? 
Others (specify) 
Wedner, 
2008 
Low Low Low Unclear Low Low Unclear Yes limitations are made clear - 
results are internally valid 
Ma, 2014 Low Low Low Low Low Unclear Low Yes limitations are made clear - 
results are internally valid 
Ma, 2015 Low Low Low Low Low Unclear Low Yes limitations are made clear - 
results are internally valid 
Yi, 2015 Low Low Low Low Low Unclear Unclear Yes limitations are made clear - 
results are internally valid 
Morjaria, 
2017 
Low Low Low Low Low Low N/A Yes limitations are made clear - 
results are internally valid 
Congdon, 
2011 
Low Low Unclear Unclear Low High (Some planned results to be 
reported from the registration of the trial 
not reported) 
N/A Yes limitations are made clear - 
results are internally valid 
Zeng,2009 Low Low Low Low Low High (Some planned results to be 
reported from the registration of the trial 
not reported) some of the missing. 
outcomes will have been of relevance 
to this review e.g. continued spectacle 
use 
at 6-12 months after dispensing and cost-
effectiveness 
N/A Yes limitations are made clear - 
results are internally valid 
Zhou, 2017 Low Low Low Low Low Low N/A Yes limitations are made clear - 
results are internally valid 
Wang, 
2017 
Unclear Low Low Low Low Low Unclear Yes limitations are made clear - 
results are internally valid 
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Ma,2018 Unclear Low Low Unclear Low Low Low Yes imitations are made clear - 
results are internally valid 
Kaey, 2010 N/A Low Low Low Low High (Some planned results to be 
reported from the registration of the trial 
not reported) some of the missing 
outcomes will have been of relevance 
to this review e.g. continued spectacle 
use 
at 6-12 months after dispensing and cost-
effectiveness 
N/A Yes limitations are made clear - 
results are internally valid 
Narayanan, 
2018 
N/A unclear Unclear low Low Low N/A Yes limitations are made clear - 
results are internally valid 
Priya, 2014 N/A Unclear Low Unclear Low Low N/A Yes limitations are made clear - 
results are internally valid 
 
J 
 
Figure 15: Risk of bias assessment for randomized and non-randomized control trial 
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4.7 Risk of bias assessment (Prevalence studies) 
 
Risk of bias assessment for prevalence studies was done using the Hoy risk of bias assessment tool which was modified to suit 
this systematic review. Table 6 and figure 16 summarizes the risk of bias assessment for all the prevalence studies. 
Table 6: Quality assessment for prevalence studies 
 
Study, year  
Was the 
study’s target 
population a 
close 
representation 
of the national 
population in 
relation to 
relevant 
variables, e.g. 
age, sex, 
occupation? 
 
 
Was the 
sampling 
frame a true 
or close 
representation 
of the target 
population? 
 
Was some 
form of 
random 
selection 
used 
to select the 
sample? OR, 
was a 
census 
undertaken? 
 
Was the 
likelihood 
of nonresponse 
bias minimal? 
Were 
data 
collected 
directly 
from the 
subjects 
(as 
opposed 
to a 
proxy)? 
Was an 
acceptable 
case 
definition 
used in 
the study? 
 
Was the 
study instrument 
that measured 
the parameter 
of interest 
(e.g. prevalence) 
shown to have 
reliability 
and validity 
(if necessary)? 
 
Was the 
same mode 
of data 
collection 
used for all 
subjects? 
Was the 
length of 
the shortest 
prevalence 
period for 
the 
parameter 
of interest 
appropriate? 
Were the 
numerator 
(s) 
and 
denominat
or(s) 
for the 
parameter 
of interest 
appropriat
e? 
Overall 
Score 
 
Risk of bias 
Gogate, 2013 No Yes Yes Yes Yes Yes Yes Yes N/A Yes 7 Moderate 
Shukla, 2018 No Yes Unclear Yes Yes Yes Yes Yes N/A Yes 6 Moderate 
Aldebasi,2013 Yes Yes Unclear Yes Yes Unclear Yes Yes N/A Yes 7 Moderate 
Limburg, 
1995 
No Unclear Unclear Unclear Yes Yes Yes Yes N/A Yes 5 High 
Sumana, 
2015 
No Yes Yes Yes Yes Yes Yes Yes N/A Yes 8 Low 
Khandekar, 
2008 
Yes Yes Unclear Yes Yes Yes Yes Yes N/A Yes 8 Low 
Bhandari, 
2016 
Unclear Yes Yes Yes Yes Yes Yes Yes N/A Yes 8 Low 
Pavithra, 
2014 
No Yes No Yes Yes Yes Yes Yes N/A Yes 7 Moderate 
Bhatt, 2017 No Unclear No Unclear Yes Yes Yes Yes N/A Yes 5 High 
Tengtrisorn, 
2009 
Yes Yes No Yes Yes Yes Yes Yes N/A N/A 7 Moderate 
Scoring: LOW RISK OF BIAS: 8 or more “yes”; MODERATE RISK OF BIAS: 6 to 7 “yes”; HIGH RISK: 5 or fewer 
“yes”; N/A. not applicable 
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Figure 16: Risk of bias assessment chart for prevalence studies 
 
 
4.8 Risk of bias assessment (cohort studies) 
 
Risk of bias assessment for cohort studies was done using a risk of bias assessment tool 
for cohort studies developed by Cochrane. Table 7 and figure 17 summarizes the risk of 
bias assessment for all the cohort studies included in this systematic review. 
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Table 7: Risk of bias assessment for cohort studies 
 
Study, year Was 
selection of 
exposed 
and non- 
exposed 
cohorts 
drawn from 
the same 
population? 
Can we be 
confident in the 
assessment of 
exposure? 
Can we be 
confident 
that the 
outcome of 
interest was 
not present 
at the start 
of the study 
Did the study match 
exposed and 
unexposed for all 
variables that are 
associated with the 
outcome of interest or 
did the statistical 
analysis adjust for 
these prognostic 
variables? 
Can we be 
confident in the 
assessment of the 
presence or 
absence of 
prognostic 
factors? 
Can we be 
confident in 
the assessment 
of outcome? 
Was the 
follow up of 
cohorts 
adequate? 
Were 
co‐Interventions 
similar 
between 
groups? 
Overall 
score 
Risk of 
Bias 
Von- Bischhoffshausen, 
2014 
N/A Definitely yes Definitely 
yes 
N/A Mostly yes Definitely yes Definitely 
yes 
N/A   
Congdon,2008 Definitely 
yes 
Definitely yes Definitely yes Mostly yes Probably yes Probably yes Definitely yes N/A 3 Moderate 
Castanon, 2006 Mostly yes Definitely yes Definitely yes Mostly yes Mostly yes Definitely yes Definitely yes N/A 4 Moderate 
Rewri,2013 N/A Definitely yes Definitely yes N/A Probably yes Probably yes Probably no N/A 2 High 
Rustagi,2012 N/A Definitely yes Definitely yes N/A Probably No Definitely yes Definitely yes N/A 4 Moderate 
Limburg, 1999 N/A Probably No Mostly yes N/A Probably No Probably yes Definitely yes N/A 1 High 
5 or more “definitely yes” Low risk of bias, 3-4 “definitely yes” moderate risk of bias, 2 or few “definitely yes” high risk 
 
 
Figure 17: Risk of bias assessment chart for cohort studies 
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4.9 Quantitative Data synthesis 
 
4.9.1 Outcome: Effectiveness of school vision screening programs in reducing 
children with uncorrected refractive error 
a. Reduction in the proportion of children with uncorrected refractive error, 2 
months after a school vision screening 
One study (110) suggests that school vision screening may be effective in reducing the 
proportion of children with an uncorrected refractive error by 81% (95% CI: 77%; 
84%), two months after its introduction (figure 18). This was judged to be moderate 
certainty evidence, downgraded one level for indirectness as this effect estimate might 
only be specific to China where the study was conducted. 
 
Figure 18: Forest plot showing a reduction in the proportion of children with an 
uncorrected refractive error at 2 months 
 
 
 
b. Reduction in the proportion of children with uncorrected refractive error, 6 
months after a school vision screening 
Five studies (11, 104-106, 127) assessed the reduction in the proportion of children with 
an uncorrected refractive error at 6 months after school vision screening. These studies 
show that school vision screening programs may be effective in reducing the proportion 
of children with an uncorrected refractive error by 24% (95% CI: 13%; 35%, 
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I2=95%), (figure 19). We judged this to be moderate certainty evidence, downgrading 
one level for inconsistency. 
 
 
Figure 19: Forest plot showing a reduction in the proportion of children with an 
uncorrected refractive error at 6 months 
 
 
c. Reduction in the proportion of children with uncorrected refractive error, 8 
months after a school vision screening 
This was assessed by one study (102). This study shows that school vision screening 
programs may be effective in reducing the proportion of children with an uncorrected 
refractive error by 20% (95% CI: 18%; 22%), (figure 20) at 8 months after its 
introduction. 
We judged this to be moderate certainty evidence, downgrading one level for 
indirectness since the effect estimate may be specific to China where the study was 
conducted. 
 
Figure 20: Forest plot showing a reduction in the proportion of children with an un-
corrected refractive error at 8 month 
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Table 8: Reduction in the proportion of children with un/undercorrected refractive error 
 
Study ID Study design Follow-Up 
Period 
Number 
assessed for 
compliance at 
baseline 
Number 
Eligible for 
follow-up 
Number 
assessed for 
compliance at 
follow-up 
% 
Follow- 
Up 
Definition of 
Compliance 
The proportion 
of children 
with un/under 
corrected RE at 
baseline 
(Before School 
vision 
screening) 
The proportion 
of children 
with un/under 
corrected RE at 
follow-up 
(After School 
vision 
screening) 
Reduction in Proportion 
of children with 
un/under corrected RE 
at follow-up (After 
School vision screening) 
(95% CI) 
Zhou, 2017 randomized, double- 
masked non-inferiority 
trial 
2 Month 
period 
426 426 426 100% Self-reported wear 84.5% 
(n=360) 
4% 
(n=17) 
80.5% (CI: 77%, 84%) 
Wedner, 2008 Cluster randomized 
trial 
6 month 
period 
124 125 108 86% Wearing or Having 
spectacle at school 
93.6% 
(n=116) 
63% 
(n=68) 
30.6% (CI: 21%, 41%) 
Wang, 2017 cluster randomized, 
investigator-masked, 
controlled trial 
6 month 
period 
882 882 867 98.3% Wearing or Having 
spectacle at school 
88.2% 
(n=778) 
76.4% 
(n=662) 
11.8% (CI 8%, 15%) 
Ma, 2018 cluster randomized, 
investigator-masked, 
controlled trial 
About 6 month 
period 
949 949 949 100% Self-reported wear 71.2% 
(n=676) 
35.5% 
(n=337) 
35.7 (32%, 40%) 
Shukla, 2018 cross-sectional study About 6 month 
period 
242 186 158 84.9% Wearing or Having 
spectacle at school 
76.9% 
(n=186) 
63.9% 
(n=101) 
13% (CI: 4%, 22%) 
Yi, 2015 Cluster randomized 
trial 
6 month 
period 
728 728 693 95.2% Wearing or Having 
spectacle at school 
82.1% 
(n=598) 
54.3% 
(n=376) 
27.8% (CI: 23%, 33%) 
Ma, 2015 Cluster randomized 
trial 
8 Month 
period 
3177 3177 3177 100% Wearing or Having 
spectacle at school 
85.0% 
(n=2714) 
65.50 
(n=2081) 
19.5% (CI: 18%, 22%) 
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4.9.2 Outcome: School vision screening and compliance with spectacle wear 
 
a. Spectacle compliance Less than three months after a school vision screening 
 
Compliance with spectacle wear at less than 3 months after school vision screening 
was assessed by three studies, (110, 111, 117). These studies show that 54% of 
children provided with spectacles as part of school vision screenings may be 
compliant with it wear at less than 3-month follow-up (95% CI: 25%; 100%, 
I2=100%) (Figure 21). We judged this to be moderate certainty evidence 
downgrading 1 level for inconsistency. The level of spectacle compliance differed 
(high heterogeneity) based on the definition used in the various studies. One study 
(110) which defined spectacle compliance as ‘self-reported wear by children’ on the 
day of the assessment, found it to 96% (95% CI: 94%; 98%). Another study (111) 
which defined spectacle compliance as ‘wearing or having at school’ on the day of 
assessment found it to be 49% (CI: 45%; 54%), while a study (117) which defined 
compliance as ‘observed wear’ on the day of assessment found it to be relatively 
low; 33% (95% CI: 29%; 37%). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21: Forest plot showing spectacle compliance at < 3 month 
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b. Spectacle compliance three months after a school vision screening 
 
Six studies (11, 108, 121, 123, 125, 126) assessed spectacle compliance at 3 months 
after school vision screening. These studies indicate that 57% of children provided 
with spectacles as part of school vision screening programs may be compliant with 
it wear at three-month follow-up (95% CI: 46%; 70%, I2=94%) (Figure 22). We 
judged this evidence to be of low certainty, downgrading 2 levels for high risk of 
bias and inconsistency. 
 
Four studies of these studies (11, 108, 123, 126) defined spectacle compliance as 
‘wearing or having spectacle at school’ and found 62% of children to be compliant 
with it wear (95% CI: 51%; 77%, I2=93%). Two studies (121, 125) which defined 
compliance as ‘observed spectacle wear’ on the day of assessment found 57% of 
children to be compliant with it wear (95% CI: 47%; 70%, I2=94%). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22: Forest plot showing spectacle compliance at 3 months 
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c. Spectacle compliance six months after a school vision screening 
 
This was reported by nine studies (11, 104-107, 115, 119, 127, 128). These studies 
revealed that 38% of children provided with spectacles as part of school vision 
screening may be compliant with it wear at six-month follow-up (95% CI: 29%; 
51%, I2=94%], moderate certainty evidence (downgraded one level for 
inconsistency) (Figure 23). 
One study (104) which defined spectacle compliance based on ‘self-reported wear’ 
found compliance among school children to be relatively high, 64% (95% CI: 62%; 
68%) while five studies (11, 105-107, 115) which defined compliance as children 
‘wearing or having their spectacles at school’ on the day of assessment found the 
pooled spectacle compliance among children to be low; 32% (95% CI: 23%; 45%, 
I2=97%, moderate certainty evidence). 
 
Three studies (119, 127, 128) defined spectacle compliance based on ‘observed 
wear’ on the day of assessment and found the pooled spectacle compliance among 
children to also below 35% (95% CI: 32%; 39%, I2=25%, moderate certainty 
evidence). 
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Figure 23: Forest plot showing spectacle compliance at 6 months 
 
 
d. Spectacle compliance more than six months after a school vision screening 
 
Seven studies (10, 102, 114, 116, 118, 120, 122) assessed spectacle compliance at 
more than 6 months after school vision screening. The results of these studies 
indicate that 41% of children provided with spectacles as part of school vision 
screening may be compliant with it wear at more than six months follow-up (95% 
CI: 24%; 68%, I2=100 %,) (Figure 24). We judged this to be low certainty evidence, 
downgrading 2 levels for high risk of bias and inconsistency. 
 
One of these studies from India, (116) which defined spectacle compliance based on 
‘teacher reported wear’ found the level of spectacle compliance among children to be 
very high; 96% (95% CI: 96%; 97%). This study was however judged to have a high 
risk of bias. (Table 6) 
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Three of the studies; (102, 114, 120) which defined compliance as ‘wearing or 
having spectacle at school’ on the day of assessment found the pooled spectacle 
compliance among children to be relatively low; 34% (95% CI: 11%; 100%, I2=100 
%, Low certainty evidence). 
 
 
Two studies; (118, 122) which defined spectacle compliance as ‘observed wear” by 
children on the day of assessment found the level of spectacle compliance among 
children to be even lower 32% (95% CI: 14%, 72%, I2=24 %, moderate certainty 
evidence). 
Definition of spectacle compliance was not clearly reported by one study (10). The 
authors, however, reported that regular use of spectacle was found among 20.4% 
(95% CI 12%; 35%) 
 
 
Figure 24: Forest plot showing spectacle compliance at >6 month 
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Spectacle compliance < 3 months after a school vision 
screening 
Study ID Study design Follow-Up 
Period 
Number 
Eligible for 
follow-up 
Number 
assessed/sampled 
for compliance 
% Follow-Up Definition of Compliance Spectacles wearing (compliance) 
At < 3 month Follow-up 
Zhou, 2017 randomized, double-masked non- 
inferiority trial 
2 Month period 426 426 100% Self-reported wear 96% 
(n=409) 
Kaey,2010 prospective clinical trial 1-month period 428 415 97% Wearing or Having spectacle 
at school 
49.2% 
(n=204) 
Rewri,2013 prospective cohort 
study 
2-month period 742 493 66% Observed wear 32.7% 
(n=161) 
 
Spectacle compliance 3 months after a school vision 
screening 
Khandekar, 2008 cross-sectional 
descriptive study 
3- 4-month 
period 
77 77 100% Wearing or Having spectacle 
at school 
80.5% 
(n=62) 
Wedner, 2008 Cluster randomized trial 3&6-month 
period 
125 108 86% Wearing or Having spectacle 
at school 
37.0% 
(n=40) 
Morjaria, 2017 Non-inferiority, double masked, 
randomized clinical trial 
3-4-month 
period 
460 362 78.7% Wearing or Having spectacle 
at school 
74.6% 
(n=270) 
Pavithra, 2014 cross-sectional study 3-month period 97 83 85.6% Observed wear 57.8% 
(n=48) 
Bhatt, 2017 cross-sectional study 3-month period 200 200 100% Observed wear 39% 
(n=78) 
        
McCormick, 2018 Cross-sectional study 3-4-month 
period 
286 193 67.4% Wearing or having spectacle 
at school 
60.1% 
(n=116) 
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Spectacle compliance 6months after a school vision 
screening 
Yi, 2015 Cluster randomized trial 6-month period 728 693 95.2% Wearing or Having spectacle 
at school 
45.7% 
(n=376) 
Congdon, 2011 Randomized, controlled trial. 6-month period 4448 3200 71.94% Wearing or Having spectacle 
at school 
25.3% 
(n=810) 
Wang, 2017 cluster randomized, investigator- 
masked, controlled trial 
6-month period 882 867 98.3% Wearing or Having spectacle 
at school 
23.6% 
(n=205) 
Ma, 2018 cluster randomized, investigator- 
masked, controlled trial 
About 6-month 
period 
949 949 100% Self-reported wear 64.5% 
(n=612) 
Congdon,2008 Prospective study 
(cohort) 
4-11-month 
period, mean 
6.4 months 
810 483 60% Wearing or Having spectacle 
at school 
44.7% 
(n=216) 
Shukla, 2018 cross-sectional study About 6-month 
period 
186 158 84.9% Observed wear 36.1 
(n=57) 
Aldebasi,2013 cross-sectional 
descriptive study 
6 month period 631 631 100% Observed wear 33.1% 
(n=209) 
Sumana, 2015 cross-sectional 
descriptive study 
6-month period 362 318 88% Observed wear 38.4% 
(n=122) 
Wedner, 2008 Cluster randomized trial 3&6-month 
period 
125 108 86% Wearing or Having a 
spectacle 
at school 
42.6.% 
(n=46) 
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Spectacle compliance >6 months after a school vision screening 
 
Von-    
Bischhoffshausen, 
2014 
Cohort study 12 Month 
period 
204 199 97.5% Observed wear 58.3% 
(n=116) 
Gogate, 2013 Cross-sectional follow-up study 12 Month 
period 
1035 1018 98.3% Observed wear 31% 
(n=315) 
Rustagi,2012 intervention study 8-month period 51 49 96.1% Not clearly defined (reported 
as “regular use” by authors) 
20.4% 
(n=10) 
Limburg, 1999 Retrospective 
Cohort study 
60-month 
period 
43922 43922 100% Teacher reported 96.5% 
(n=42390) 
Castanon, 2006 prospective cohort 
study 
18-month 
period 
493 493 100% Wearing or Having spectacle 
at school 
47.7% 
(n=235) 
Ma, 2015 Cluster randomized trial 8 Month period 3177 3177 100% Wearing or Having spectacle 
at school 
34.50% 
(n=1096) 
Bhandari, 2016 population- based, cross – 
sectional study 
12-month 
period 
170 170 100% Wearing or Having spectacle 
at school 
28.2% 
(n=48) 
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4.9.3 Outcome: Cost-effectiveness of school vision screening 
 
Five studies (11, 103, 113, 124, 129) reported school vision screenings to be cost-
effective (Moderate certainty evidence). One study (11) estimated the overall cost 
of screening and provision of spectacle for each student to be $0.87. This was 
reported to be nearly one-fourteenth of the Tanzania total health expenditure on 
health of $12 per capita in 2004. This evidence was however judged to be of low 
certainty after downgrading two levels for indirectness since the cost estimate was 
specific to Tanzania and estimation was done about ten years ago. 
 
One study (103) estimated the cost of buying high quality spectacles in bulk which is 
normally the case in most school vision screening programmes to be less than $5 
compared to the median price of approximately $60 (almost half the monthly income 
for rural families in China) paid by each child who owned a pair of spectacles 
outside the school vision screening context. We judged this to be moderate certainty 
evidence, downgrading one level for indirectness since the cost estimate was specific 
to China. 
 
 
One study (113) compared the cost of screening per child using an “all class teacher 
model” versus a “selected class teacher model” in India and found school vision 
screening programs involving all class teachers to be efficient and cost-effective 
(moderate certainty evidence). The cost of screening one child using the ‘all class 
teacher model” was estimated to be $ 1.91 compared to the $4.83 per child screened 
using the “selected teacher model” 
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One study (124) estimated the overall cost of screening one child based on the cost of 
the materials used in school vision screening (visual acuity cards, tape measure, etc.). 
The cost of screening one child with no refractive error was estimated to be less than 
$0.03 while the cost of screening and providing spectacles for a child with the 
refractive error was estimated to be $2.55. We judged this to be low certainty 
evidence downgrading two levels for indirectness since the cost estimate was 
specific to India and cost estimation was done about 23 years ago. 
 
The direct cost of screening one student with no ocular abnormality (excluding 
project management and traveling expenses) was estimated by one study (129) to be 
approximately $0.5. This cost, however, increased to $34.2 per child for 
implementation of nationwide programs targeting children with treatable mild, 
moderate and severe problems and $76.2 for nationwide programs targeting only 
children with moderate and severe conditions. The certainty of this evidence was 
judged by us to be low, downgraded 3 levels for imprecision based on the risk of 
bias assessment and indirectness as cost estimate is specific to Thailand and 
estimation was done 9 years ago. 
 
4.9.4 Outcome: Impact of school vision screening on the academic 
performance of children 
Five studies; (103, 104, 106, 122, 126) reported on the impact of school vision 
screening on the academic performance of children. All five studies reported that 
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school vision screenings had a positive impact on the academic performance of 
children. Improvement in mathematics test score from 0.22 (SD; 0.99) at baseline to 
0.34 (SD; 0.99), eight months after school vision screening (change of 0.13, CI: 
0,008-0.17) was reported by one study (103). The authors reported that despite the 
low level of compliance with spectacle wear observed in the study, screening, and 
provision of spectacles had a statistically significant impact on the academic 
performance of children. We judged this to be moderate certainty evidence; 
downgrading one level for indirectness. 
 
One study (106) compared the improvement in mathematics test score between 
children who received free spectacles and teacher incentive to improve spectacle 
compliance with and that of children who only received a prescription for spectacle 
and found an improvement in mathematics test score in the two groups, six months 
after school vision screening. The authors reported that children in schools that 
received the free spectacles and teacher incentive as part of school vision screening 
performed slightly better in the mathematics test but this was not statistically 
significant. We graded this evidence to be of moderate certainty, downgrading one 
level for indirectness. 
 
In one study (104), improvement in mathematics test score was compared between 
children in the “early referral to the hospital” and “late referral to hospital” group. 
The mean baseline mathematics test score was reported to be 0.09 (SD; 1.1) and -
0.05 (SD; 1.0) in the “early referral to hospital” and “late referral to hospital” 
groups respectively. The mean mathematics test score increased at 6 months 
follow up to 
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0.14 (SD; 1.01) and -0.16 (0.97) in the “early referral to the hospital” and “late 
referral to hospital” group respectively with the adjusted effect on mathematics test 
score comparing the two groups reported being 0.25 SD (95% CI, 0.01; 0.48, 1-sided 
P=0.04). The authors reported that this point estimate of the effect of the intervention 
was equivalent to half a semester additional learning. We graded this to be moderate 
certainty evidence, downgrading one level for indirectness. 
 
One study (126) reported that among children who were compliant to wearing 
spectacles prescribed as part of school vision screening, 42 (87.5%) had an 
improvement in academic performance which was confirmed in 36 (85.7%) of the 
students by teachers. We judged this to moderate certainty evidence after 
downgrading one level for indirectness. 
Another study (122) also reported a higher average academic score among children 
who were compliant with spectacle wear compared to those who were non-compliant 
but this evidence was judged to be of low certainty, downgrading two levels for 
imprecision (a small number of events) and indirectness. 
 
4.9.5 Outcome: The adverse effect of school vision screening 
 
The adverse effect of school vision screening was reported by three studies (106, 
108, 109). One study (106) reported a reduction in LogMar visual acuity from 0.59 
(SD; 0.22) at baseline to 0.71(SD 0.21) at six-month follow-up with a change of -
0.12 (95% CI 0.14, 0.10). This evidence was judged to be of moderate certainty 
after downgrading one level for indirectness. 
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One study (109) found spectacles provided as part of school vision screening to be 
associated with 27.2% report of headache, 34.6% report of dizziness, 6.18% report of 
disorientation, 9.90% of nausea and 48.76% of eye strain. This reported effect 
however reduced to 21.50% headache, 7.00% disorientation, 22.2% dizziness, 7.48% 
nausea and 48.55% eye strain at 1-month follow-up. We judged this to be moderate 
certainty evidence. 
 
Another study (108) also reported the presence of symptoms of headache and 
dizziness among children who received spectacles at the start of the school vision 
screening which reduced at a one-month follow-up. 
 
5.0 Discussion 
 
5.1 Summary of main results 
 
School vision screening programs for refractive error are mainly aimed at reducing 
the number of children with uncorrected refractive error. Effectiveness of these 
programs depends on correctly identifying children with uncorrected refractive 
errors. In addition, it also depends on ensuring that children identified with the 
condition are given the appropriate spectacle or contact lens correction at reasonable 
costs, and these spectacles or contact lenses are worn on regular basis (compliance). 
The purpose of this review was to assess the effectiveness of school vision screening 
programs in reducing children with uncorrected refractive error and evaluate the 
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level of compliance with wearing of spectacles provided as part of school vision 
screening programs. We further sought to assess the cost-effectiveness of school 
vision screening programs, the effect of school vision screenings on the academic 
performance of children and adverse effect of school vision screenings in the LMIC 
context. 
Our review found that introducing vision screening programs in schools may be an 
effective way of reducing the number of children with uncorrected refractive error. 
Considering the fact that the provision of free spectacles to children with 
uncorrected refractive error has become central to most school vision screening 
programs in recent times, this finding is not unexpected. 
 
This review also found school vision screening together with the provision of 
spectacles be relatively cost-effective. This result agrees well with a recent 
Cochrane review 
(13) which found vision screening and provision of spectacles to be a relatively cost-
saving way of correcting children with uncorrected refractive error in the LMIC 
settings. 
 
 
In terms of the impact of school vision screening programs on the academic 
performance of children, our review found a positive association between the 
introduction of school vision screening programs and improvement in the academic 
performance of children. This result also agrees with a recent Cochrane review (13) 
which to the best of our knowledge is the only systematic review that has attempted 
to assess the impact of school vision screening on the academic performance of 
children in the LMIC context. 
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While symptoms such as dizziness, disorientation, nausea, and eye strain were found 
to be associated with the initial use of spectacles provided as part of school vision 
screening programs, our review found that these symptoms improved significantly at 
follow-up indicating that school vision screening is relatively safe in identifying and 
treating children with uncorrected refractive error. 
Compliance with the wearing of spectacles provided as part of school vision 
screening, similar to a Cochrane review (13) was found to vary among the various 
studies and ranged between 32% to 96%. The possible reason for this could be the 
different definition of compliance used in these studies. Spectacle compliance was 
defined as ‘wearing or having it at school’, ‘self-reported wear’ or ‘observed wear’ 
by the various studies included in this systematic review. Considering the fact that 
the different definition used as an indication of spectacle compliance by the various 
studies could have had an effect on the pooled spectacle compliance found in this 
review, we conducted a sub-group analysis based on the definition and the result is 
presented in Figure 21, Figure 22, Figure 23 and Figure 24. This should be taken 
into consideration when interpreting the result of this review. 
 
5.2 Overall Completeness and applicability of evidence 
 
Considerable effort was made to ensure the overall completeness of this 
systematic review by including all studies conducted in LMIC that assessed our 
review objectives. Our study found school vision screening programs to be a 
relative cost-effectiveness method of reducing the proportion of children with 
uncorrected refractive error. Despite a comprehensive search strategy to ensure all 
studies 
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conducted in LMIC that met our eligibility criteria were included, most of the papers 
included in this review came from Asia and the applicability of this evidence to other 
LMIC where none of the included studies came from may be limited. This is 
especially the case as vision screening programs have been shown to vary across 
different settings. This means that the result of this review should be applied with 
cautious when assessing the effectiveness of school vision screening in other 
countries or settings especially those outside the LMIC. 
 
Another important limitation of this review is that the pooled spectacle compliance 
found in this review was obtained from studies that used different definitions as an 
indication of spectacle compliance. Studies that defined spectacle compliance based 
on ‘self-reported wear’ reported a higher level of compliance which may have 
overestimated the overall effect and studies that defined spectacle compliance based 
on ‘observed wear’ reported lower spectacle compliance which may have 
underestimated the pooled spectacle compliance. This should be taken into 
consideration in interpreting the result of this review. 
 
This review also included only papers published in the English language. This means 
that papers published in other languages were missed and the effect of excluding 
these papers on the overall effects reported in this review is not clear. 
 
5.3 Certainty of evidence 
 
We made use of the GRADE approach to judge the certainty of the evidence 
presented in this systematic review. Our primary outcome was graded as moderate 
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certainty evidence, usually downgrading one level for either inconsistency or 
indirectness. 
 
Concerning spectacle compliance, all the outcomes presented in this review were 
graded as moderate certainty evidence except spectacle compliance at three months 
and more than three months post-school vision screening which were graded as low 
certainty evidence, downgrading two levels for high risk of bias and inconsistency. 
 
The outcomes for the cost-effectiveness of school and impact of school vision 
screening on academic performance of children were graded as moderate certainty 
evidence, downgrading one level in both cases for indirectness as estimates are 
more likely to be specific to the countries in which the included studies were 
conducted. 
The outcome for the adverse effect of school vision screening was graded as high 
certainty evidence. 
 
5.4 Potential bias in the review process 
 
An effort was made to reduce bias in the conduct of this systematic review by 
conducting a comprehensive and systematic search for eligible papers, involving two 
independent reviewers in the assessment of study eligibility, extraction of study data 
and assessment of the risk of bias of the included studies. The review was however 
limited to studies published in the English language and the effect of excluding these 
studies on the outcome reported in this review is not clear. The potential bias that 
could have resulted from reporting the result of this systematic review was also 
avoided by adhering to the PRISMA guidelines. 
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5.5 Agreement and disagreement with other studies or reviews 
 
To the best of our knowledge, no current systematic review has assessed the 
effectiveness of school vision screening in reducing the proportion of children with 
uncorrected refractive error. One Cochrane review (13) assessed the cost-
effectiveness and impact of school vision screening on the academic performance of 
children. Our result on cost-effectiveness and impact of school vision screening 
agrees well with the result of this Cochrane review. The outcome for the level of 
compliance with spectacle wearing found in this systematic review is slightly lower 
than was reported in the Cochrane review (13). This outcome was however assessed 
from ten studies compared to only two studies from the Cochrane review and the use 
of “observed wear’ as indication for spectacle compliance in eight of the studies 
included in our review compared to “self-reported wear’ in the two studies included 
in the Cochrane review could have led to an over-estimation of the pooled level of 
spectacle compliance found in the Cochrane review. 
 
6.0 Authors’ conclusion 
 
6.1 Implication for practice 
 
Result of this review shows that school vision screening together with the provision 
of spectacle may be a safe and cost-effective way of reducing the proportion of 
children with uncorrected refractive error. Most of the studies included in this review 
were conducted in Asia and the applicability of this finding to countries in other 
regions of the world especially those outside the LMIC circle is not clear. 
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6.2 Implication for research 
 
RCTs assessing the effectiveness of health intervention are known to provide the 
highest form of evidence compared to other study designs. Our review found no RCT 
that compared school vision screening to no vision screening which in our opinion 
will have provided better evidence of the effectiveness of school vision screening in 
resource-limited settings. Additionally, considerable variation was found in the 
definition of spectacle compliance by the various studies which likely had an effect 
on the pooled spectacle compliance reported in this review. Establishing a common 
global definition for spectacle compliance to be used in subsequent studies may be an 
effective way to ensure accurate estimation of overall spectacle compliance in 
subsequent reviews. 
 
This review further found only a few studies conducted outside Asia that assessed 
the effectiveness of school vision screening, limiting the applicability of the 
outcome of this review to that area. Studies especially RCTs aimed at assessing the 
effectiveness of school vision screening in areas where no studies were found is 
highly recommended. 
As this was a mini-dissertation which required focussing on fewer secondary 
objectives, this review was unable to assess the barriers to school vision screening 
and available evidence regarding the benefits of integrating school vision screening 
into the global educational system. Reviews that seek to add to knowledge in this 
area is also highly recommended 
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5.0 APPENDICES 
5.1 Search strategy 
PubMed Search strategy, modified as needed for other electronic databases 
 
Population 
1. MeSH Child [MeSH] OR Adolescents [MeSH] 
2. Free text Child OR children OR adolescent OR adolescents OR teenager OR teenagers OR student OR students OR pupil 
OR pupils OR learner OR learners OR pediatric OR pediatric 
3. 1 OR 2 
 
4. MeSH Schools [MeSH] OR School Health Services [MeSH] 
5. Free text School OR schools OR preschool OR preschools OR school-based OR educational intervention 
6. 4 OR 5 
7. 3 AND 6 
Intervention 
8. MeSH Vision Tests [MeSH] 
9. Free Text Eye screening OR eye tests OR vision screening OR vision tests 
10. 8 OR 9 
Outcome 
11. MeSH Refractive Errors [MeSH] OR Eyeglasses [MeSH] 
12. Free text Refractive Errors OR Refractive error OR eyeglasses OR spectacles OR vision deficit OR visual acuity OR 
Myopia OR Hyperopia OR Aniseikonia OR Anisometropia OR Astigmatism 
13. 11 OR 12 
14. 7 AND 10 AND 13 
15. Filter ("deprived countries" OR "deprived country" OR "deprived nation" OR "deprived nations" OR "deprived population" 
OR "deprived populations" OR "deprived world" OR "developing countries" OR "developing country" OR 
"developing economies" OR "developing economy" OR "developing nation" OR "developing nations" OR "developing 
population" OR "developing populations" OR "developing world" OR "lami countries" OR "lami country" OR "less 
developed countries" OR "less developed country" OR "less developed economies" OR "less developed economy" OR 
"less developed nation" OR "less developed nations" OR "less developed population" OR "less developed populations" 
OR "less developed world" OR "lesser developed countries" OR "lesser developed country" OR "lesser developed 
economies" OR "lesser developed economy" OR "lesser developed nation" OR "lesser developed nations" OR "lesser 
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  developed population" OR "lesser developed populations" OR "lesser developed world" OR "LMIC" OR "LMICS" 
OR "low gdp" OR "low gnp" OR "low gross domestic" OR "low gross national" OR "low income countries" OR "low 
income country" OR "low income economies" OR "low income economy" OR "low income nation" OR "low income 
nations" OR "low income population" OR "low income populations" OR "lower gdp" OR "lower gnp" OR "lower 
gross domestic" OR "lower gross national" OR "lower income countries" OR "lower income country" OR "lower 
income economies" OR "lower income economy" OR "lower income nation" OR "lower income nations" OR "lower 
income population" OR "lower income populations" OR "Middle-income countries" OR "middle income country" OR 
"middle income economies" OR "middle income economy" OR "middle income nation" OR "middle income nations" 
OR "middle income population" OR "middle income populations" OR "poor countries" OR "poor country" OR "Poor 
Economies" OR "Poor Economy" OR "poor nation" OR "poor nations" OR "poor population" OR "poor populations" 
OR "poor world" OR "poorer countries" OR "poorer country" OR "Poorer Economies" OR "Poorer Economy" OR 
"poorer nation" OR "poorer nations" OR "poorer population" OR "poorer populations" OR "poorer world" OR "third 
world" OR "transitional countries" OR "transitional country" OR "Transitional Economies" OR "Transitional 
Economy" OR "under developed countries" OR "under developed country" OR "under developed economies" OR 
"under developed economy" OR "under developed nation" OR "under developed nations" OR "under developed 
population" OR "under developed populations" OR "under developed world" OR "under served countries" OR "under 
served country" OR "under served nation" OR "under served nations" OR "under served population" OR "under served 
populations" OR "under served world" OR "underdeveloped countries" OR "underdeveloped country" OR 
"underdeveloped economies" OR "underdeveloped economy" OR "underdeveloped nation" OR "underdeveloped 
nations" OR "underdeveloped population" OR "underdeveloped populations" OR "underdeveloped world" OR 
"underserved countries" OR "underserved country" OR "underserved nation" OR "underserved nations" OR 
"underserved population" OR "underserved populations" OR "underserved world") OR (Afghanistan OR Albania OR 
Algeria OR “American Samoa” OR Angola OR Armenia OR Azerbaijan OR Bangladesh OR Belarus OR Byelarus OR 
Belorussia OR Belize OR Benin OR Bhutan OR Bolivia OR Bosnia OR Botswana OR Brazil OR Bulgaria OR Burma 
OR “Burkina Faso” OR Burundi OR “Cabo Verde” OR “Cape verde” OR Cambodia OR Cameroon OR “Central 
African Republic” OR Chad OR China OR Colombia OR Comoros OR Comores OR Comoro OR Congo OR “Costa 
Rica” OR “Côte d'Ivoire” OR Cuba OR Djibouti OR Dominica OR “Dominican Republic” OR Ecuador OR Egypt OR 
“El Salvador” OR Eritrea OR Ethiopia OR Fiji OR Gabon OR Gambia OR Gaza OR “Georgia Republic” OR Georgian 
OR Ghana OR Grenada OR Grenadines OR Guatemala OR Guinea OR “Guinea Bisau” OR Guyana OR Haiti OR 
Herzegovina OR Hercegovina OR Honduras OR India OR Indonesia OR Iran OR Iraq OR Jamaica OR Jordan OR 
Kazakhstan OR Kenya OR Kiribati OR Korea OR Kosovo OR Kyrgyz OR Kirghizia OR Kirghiz OR Kirgizstan OR 
Kyrgyzstan OR “Lao PDR” OR Laos OR Lebanon OR Lesotho OR Liberia OR Libya OR Macedonia OR Madagascar 
OR Malawi OR Malay OR Malaya OR Malaysia OR Maldives OR Mali OR “Marshall Islands” OR Mauritania OR 
Mauritius OR Mexico OR Micronesia OR Moldova OR Mongolia OR Montenegro OR Morocco OR Mozambique OR 
Myanmar OR Namibia OR Nepal OR Nicaragua OR Niger OR Nigeria OR Pakistan OR Palau OR Panama OR 
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  “Papua New Guinea” OR Paraguay OR Peru OR Philippines OR Phillippines OR Philipines OR Philippines OR 
Principe OR Romania OR Rwanda OR Ruanda OR Samoa OR “Sao Tome” OR Senegal OR Serbia OR “Sierra Leone” 
OR “Solomon Islands” OR Somalia OR “South Africa” OR “South Sudan” OR “Sri Lanka” OR “St Lucia” OR “St 
Vincent” OR Sudan OR Suriham OR Suriname OR Swaziland OR Syria OR “Syrian Arab Republic” OR Tajikistan 
OR Tadzhikistan OR Tadjikistan OR Tadzhik OR Tanzania OR Thailand OR Timor OR Togo OR Tonga OR Tunisia 
OR Turkey OR Turkmen OR Turkmenistan OR Tuvalu OR Uganda OR Ukraine OR Uzbek OR Uzbekistan OR 
Vanuatu OR Vietnam OR “West Bank” OR Yemen OR Zambia OR Zimbabwe) 
16. 14 AND 15  
 
 
 
5.2 Data Extraction and Assessment Form (EPOC) 
DATA EXTRACTION TOOL 
 
 
 
 
 
Review title or ID 
Study ID (surname of first author and year first full report of study was published e.g. Smith 2001) 
Report IDs of other reports of this study (e.g. duplicate publications, follow-up studies) 
Notes: 
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1.0 GENERAL 
INFORMATION 
Date form completed  
Name/ID of person extracting 
data 
 
Study Title  
Author(s)  
Year  
Trial Registration Number  
Reference details  
Report author contact details  
Publication type 
(e.g. full report, abstract, letter) 
 
Study funding source 
(including the role of 
funders) 
 
Possible conflicts of interest 
(for study authors) 
 
Notes: 
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2.0 
ELIGIBILITY 
Study 
Characteristics 
Review Inclusion Criteria 
(Insert inclusion criteria for each 
characteristic as defined in the Protocol) 
 
 
Yes/ No / Unclear 
Location in text 
(pg & ¶/fig/table) 
 Type of study Randomized trial   
 Non-randomised trial   
 Controlled before-after study 
 Contemporaneous data collection 
 At least 2 intervention and 2 control 
clusters 
  
 Interrupted time series OR 
Repeated measures study 
 At least 3 time points before 
and 3 after the intervention 
 Clearly defined intervention point 
  
 Other design (specify):   
 Participants    
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2.0 
ELIGIBILITY 
Study 
Characteristics 
Review Inclusion Criteria 
(Insert inclusion criteria for each 
characteristic as defined in the Protocol) 
 
 
Yes/ No / Unclear 
Location in text 
(pg & ¶/fig/table) 
 Types of 
intervention 
   
 Types of 
outcome 
measures 
Primary Secondary   
   
 Decisio 
n: 
 Reason for 
exclusion 
 
 No
tes 
: 
 
 
 
 
 
3.0 POPULATION 
AND SETTING 
Population description 
(from which study 
participants are drawn) 
Description 
Include comparative information for each group (i.e. 
intervention and controls) if available 
Location in text 
(pg & 
¶/fig/table) 
Study Period   
Setting 
(including location and 
social context) 
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3.0 POPULATION 
AND SETTING 
Population description 
(from which study 
participants are drawn) 
Description 
Include comparative information for each group (i.e. 
intervention and controls) if available 
Location in text 
(pg & 
¶/fig/table) 
 Inclusion criteria   
 Exclusion criteria   
 Method/s of 
recruitment of 
participants 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
4.0 
METHODS 
 Descriptions as stated in report/paper Location in text 
(pg & ¶/fig/table) 
 1. Aim of the study   
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 Design 
(e.g. parallel, crossover, non- 
RCT) 
  
 Unit of allocation 
(by individuals, cluster/ groups 
or body parts) 
  
 Start date   
 End date   
 Duration of participation 
(from recruitment to last follow- 
up) 
  
 Notes: 
 
 
 
 
 
 
 
 
 
 
 
 
5.0 
PARTICIPANTS 
Country  Location in text 
Setting  
Baseline Characteristics  
  
Age 
Mean Range 
  
123 | P a g e 
 
 
   
Gender 
Males Females Total Number 
Numbe 
r (n) 
Proportion (%) Number (n) Proportion (%) 
    
Ethnic 
Group 
African Non-African  
Number 
(n) 
Proportion (%) Number (n) Proportion (%) 
    
Control Group 
( write it) 
Age Mean Range  
  
 
Gender 
Males Females Total Number 
Numbe 
r (n) 
Proportion (%) Number (n) Proportion (%) 
    
Ethnic 
Group 
African Non-African  
Numbe 
r (n) 
Proportion (%) Number (n) Proportion (%) 
     
Total no. 
randomized 
(Participants in 
Intervention and 
Control Group) 
 
Age 
Mean Range  
  
Gender Males (%) Females (%) Total No. 
Numbe 
r (n) 
Proportion (%) Number (n) Proportion (%) 
    
Ethnic 
Group 
African Non-African  
Numbe 
r (n) 
Proportion (%) Number (n) Proportion (%) 
    
Clusters (If 
applicable) 
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 Participants 
Inclusion 
Criteria 
  
Participants 
Exclusion 
Criteria 
  
Pre-treatment   
 Baseline 
imbalances 
  
 Withdrawals 
and 
exclusions 
  
 Subgroups 
measured 
  
 Subgroups 
reported 
  
6.0 
INTERVENTION 
Intervention Number 
Randomi 
zed 
Number 
followed- 
Up 
Number Reviewed Description of 
Intervention 
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Intervention 
Received by Both 
Groups/Co- 
interventions 
  
Outcome 
(Period) 
Primary Secondary  
   
Duration of 
Treatment/Interventi
on 
  
Provision of 
intervention (e.g. 
no., profession, 
training, 
ethnicity, etc. if 
relevant) 
  
Economic variables 
(i.e. intervention 
cost, changes in 
other costs as a 
result of 
intervention) 
  
7.0 OUTCOMES  
 
Primary Outcome 
Time Point Measured Start of Intervention End of Intervention 
  
Time Point Reported Start of Intervention End of Intervention 
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  Outcome definition Desirable Undesirable 
  
 
 
Secondary 
Outcome 1 
Time Point Measured Start of Intervention End of Intervention 
  
Time Point Reported Start of Intervention End of Intervention 
  
Outcome definition Desirable Undesirable 
  
 
 
Secondary 
Outcome 2 
Time Point Measured Start of Intervention End of Intervention 
  
Time Point Reported Start of Intervention End of Intervention 
  
Outcome definition Desirable Undesirable 
  
Person 
measuring/ 
reporting 
Outcome 
  
 Unit of 
Measurement (if 
relevant) 
Primary Outcome Secondary Outcome 1 Secondary Outcome 2 
Proportion (%)   
 Validation of 
Outcome Tool (If 
applicable) 
Yes No Unclear 
   
 Note   
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8.0 RESULT Outcome Intervention group Controls Comparative Risk 
  (With 95% CI) (With 95% CI) (With 95% CI) 
 Proportion of    
 Children with 
 uncorrected/ 
 under corrected 
 refractive error 
 At Baseline 
 Proportion of    
 Children with 
 uncorrected/under 
 corrected 
 refractive error 
 At 3 month 
 Follow-up 
 Proportion of    
 Children with 
 uncorrected/ 
 under corrected 
 refractive error 
 At 6 month 
 follow-up 
 Proportion of    
 Children with 
 uncorrected 
 /under corrected 
 refractive errors 
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 Beyond 6 month 
Follow-up 
   
The proportion 
of children 
wearing 
spectacles 
At Baseline 
   
The proportion 
of children 
wearing 
spectacles 
At 3 Month 
Follow-up 
   
Proportion of 
children wearing 
spectacles 
At 6 Month 
Follow-up 
   
Proportion of 
children wearing 
spectacles 
Beyond 6-month 
Follow-up 
   
Reported adverse 
effect of school 
Screening 
programmes 
(Assessed at any 
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 the point in 
the study) 
   
Reported cost-
effectiveness of 
school vision 
screening 
programs 
(Assessed at any 
point in the 
study 
   
Reported Effect 
of the Vision 
screening 
program on 
academic 
performance 
(Assessed at any 
point in the 
study) 
   
Reported effect of 
vision screening 
method on the 
effectiveness of 
school screening 
program (Assessed 
at any 
 point in the 
study 
   
130 | P a g e 
 
 
  
Number of 
missing 
participants and 
reasons 
(if applicable) 
Intervention Group Comparator 
No. Reason No. Reason 
    
No. participants 
moved from other 
group and reasons 
(if applicable) 
No Reason No  
    
Any other results 
reported 
  
Statistical 
methods used 
and 
appropriatenes
s of these 
methods 
Statistical Method 
Used 
  
Method Appropriate Yes  No Unclear 
Notes   
9.0 
APPLICABILITY 
Have important 
populations 
been excluded 
from the 
study? 
Yes  No  Unclear  
Is the intervention 
likely to be 
aimed at 
disadvantaged 
Yes  No  Unclear  
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 groups?       
Does the study 
directly 
address the 
review 
question? 
Yes  No  Unclear  
Notes  
10.0 OTHER 
INFORMATION 
Key conclusions of 
study authors 
 
References to other 
relevant studies 
 
Correspondence 
required for 
further study 
information 
(what and from 
whom) 
 
Further study 
information 
requested 
(from whom, what 
and when) 
 
Correspondence 
received 
(from whom, what 
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 and when)  
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5.3 a HOY et al (2012) Risk of Bias Tool for Prevalence Studies 
 
 
 
Name of author(s): 
Year of publication: 
Study title: 
Risk of Bias Item Risk of bias level 
  
External Validity  
1. Was the study’s target population a close 
representation of the national population in 
relation to relevant variables, e.g. age, sex, 
occupation? 
 
2. Was the sampling frame a true or close 
representation of the target population? 
 
3. Was some form of random selection used to 
select the sample, OR, was a census 
undertaken? 
 
4. Was the likelihood of non-response bias 
minimal? 
 
  
Internal Validity  
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5. Were data collected directly from the subjects 
(as opposed to a proxy)? 
 
6. Was an acceptable case definition used in the 
study? 
 
7. Was the study instrument that measured the 
parameter of interest (e.g. prevalence) shown 
to have reliability and validity (if necessary)? 
 
8. Was the same mode of data collection used 
for all subjects? 
 
9. Was the length of the shortest prevalence 
period for the parameter of interest 
appropriate? 
 
10..................................................................... 
ere the numerator(s) and denominator(s) for 
the parameter of interest appropriate? 
 
 
Summary item on the overall risk of study bias: 
 
LOW RISK OF BIAS: 8 or more “yes” answers. 
Further research is very unlikely to change our 
confidence in the estimate. 
 
 
MODERATE RISK OF BIAS: 6 to 7 “yes” answers. 
Further research is likely to have an important 
impact on our confidence in the estimate and may 
change the estimate. 
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HIGH RISK OF BIAS: 5 or fewer “yes” answers. 
Further research is very likely to have an important 
impact on our confidence in the estimate and is likely 
to change the estimate. 
 
 
5.3 b Assessment of risk of bias for randomized control trials 
 
Risk Reviewers’ Judgement Support for Judgement Location in 
Text 
Random 
Sequence 
Generation 
(Selection 
bias) 
   
Allocation 
Concealment 
(Selection 
bias) 
   
Blinding of 
participants 
and 
personnel 
(Performance 
Bias) 
   
Blinding of 
outcome 
assessment 
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(Detection 
bias) 
   
Incomplete 
outcome 
data 
(Attrition 
bias) 
   
Selective 
reporting 
(Reporting 
Bias) 
   
 
5.4 Preferred reporting items for systematic reviews and meta-analysis (PRISMA) checklist 
 
 
Section/topic 
 
# 
 
Checklist item 
Reported 
on page 
# 
TITLE  
Title 1 Identify the report as a systematic review, meta-analysis, or both. 1 
ABSTRACT  
Structured summary 2 Provide a structured summary including, as applicable: background; objectives; 
data sources; study eligibility criteria, participants, and interventions; study 
appraisal and synthesis methods; results; limitations; conclusions and 
implications of key findings; systematic review registration number. 
45-46 
INTRODUCTION  
Rationale 3 Describe the rationale for the review in the context of what is already known. 47-48 
Objectives 4 Provide an explicit statement of questions being addressed with reference to 
participants, interventions, comparisons, outcomes, and study design (PICOS). 
48 
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METHODS  
Protocol and registration 5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web 
address), and, if available, provide registration information including registration 
number. 
12 
Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow-up) and report 
characteristics (e.g., years considered, language, publication status) used as 
criteria for eligibility, giving rationale. 
49 
Information sources 7 Describe all information sources (e.g., databases with dates of coverage, contact 
with study authors to identify additional studies) in the search and date last 
searched. 
50 
Search 8 Present full electronic search strategy for at least one database, including any 
limits used, such that it could be repeated. 
115 
Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in a 
systematic review, and, if applicable, included in the meta-analysis). 
51-52 
Data collection process 10 Describe the method of data extraction from reports (e.g., piloted forms, 
independently, in duplicate) and any processes for obtaining and confirming data 
from investigators. 
52-53 
Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding 
sources) and any assumptions and simplifications made. 
52 
Risk of bias in individual 
studies 
12 Describe methods used for assessing the risk of bias of individual studies 
(including specification of whether this was done at the study or outcome level), 
and how this information is to be used in any data synthesis. 
53 
Summary measures 13 State the principal summary measures (e.g., risk ratio, the difference in means). 54 
Synthesis of results 14 Describe the methods of handling data and combining results of studies, if done, 
including measures of consistency (e.g., I2) for each meta-analysis. 
54-55 
Page 1 of 2 
 
Section/topic 
 
# 
 
Checklist item 
Reported 
on page 
# 
Risk of bias across studies 15 Specify any assessment of the risk of bias that may affect the cumulative evidence 
(e.g., publication bias, selective reporting within studies). 
53 
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Additional analyses 16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, 
meta-regression), if done, indicating which were pre-specified. 
53 
RESULTS  
Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in the 
review, with reasons for exclusions at each stage, ideally with a flow diagram. 
56 
Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study 
size, PICOS, follow-up period) and provide the citations. 
58-63 
Risk of bias within studies 19 Present data on the risk of bias of each study and, if available, any outcome-level 
assessment (see item 12). 
63-70 
Results of individual studies 20 For all outcomes considered (benefits or harms), present, for each study: (a) 
simple summary data for each intervention group (b) effect estimates and 
confidence intervals, ideally with a forest plot. 
71-86 
Synthesis of results 21 Present results of each meta-analysis done, including confidence intervals and 
measures of consistency. 
71-78 
Risk of bias across studies 22 Present results of any assessment of the risk of bias across studies (see Item 15). 63-70 
Additional analysis 23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, 
meta-regression [see Item 16]). 
53 
DISCUSSION  
Summary of evidence 24 Summarize the main findings including the strength of evidence for each main 
outcome; consider their relevance to key groups (e.g., healthcare providers, 
users, and policy makers). 
86-88 
Limitations 25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review- 
level (e.g., incomplete retrieval of identified research, reporting bias). 
88-89 
Conclusions 26 Provide a general interpretation of the results in the context of other evidence 
and implications for future research. 
91-92 
FUNDING  
Funding 27 Describe sources of funding for the systematic review and other support (e.g., the 
supply of data); the role of funders for the systematic review. 
N/A 
 
From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA  
Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097 
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5.5 Plos one manuscript guide 
 
